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OPTIMIZATION AND CHARACTERIZATION OF LAB-ON-A-CHIP ELEMENTS:
MICROFLUIDIC CHAMBERS AND MICRONEEDLES
Puneet Khanna
ABSTRACT

In this work, MEMS based fabrication is used to engineer multifaceted
enhancements to microfluidic systems such as lab-on-a-chip devices. Two specific
elements of microfluidic systems are the focus of this study: microfluidic chambers and
microneedles. Microfluidic chambers, which are back-end passive elements, via
proposed material and structural modifications, are shown to exhibit reduced nonspecific DNA binding and enable increased cell lysis efficiency. Microneedles, which are
front-end interfacing elements, have been fabricated in silicon and in silicon dioxide
varieties. The geometry of silicon microneedles has been varied via DRIE processing to
yield sharpened tips. Sharpening of microneedle tips provides reduced skin insertion
force without compromising structural strength. Variation of skin insertion force of
microneedles with change in tip sharpness has been studied, and toughness of human
skin derived to be approximately 26 kJ/m2. The axial and shear fracture limits of the
microneedles have also been studied. Axial fracture of 36 gauge silicon needles takes
place at an average force of 740gf. Shear fracture force of silicon needles varies from
275gf (33 gauge needles) to 35.6gf (36 gauge needles). Fracture limits of circular and
square shaped silicon dioxide needles show reduced strength of square needles; which
is pronounced in the case of shear fracture.
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CHAPTER 1
INTRODUCTION

Recent advances in genetic and tissue engineering, molecular biology,
biochemistry, embryology and cell biology have triggered a need for increased
customization of ancillary technologies. Specifically, Bio-MEMS/micromachining
technology is playing a proactive role in assisting explorations into uncharted research
territory, and at the same time enabling the surge to miniaturize and mobilize established
protocols. In this work, MEMS based fabrication is used to engineer multifaceted
enhancements to microfluidic systems such as ‘Lab-on-a-chip’ (LOC) devices.

1.1 Lab-on-a-Chip Devices
A lab-on-a-chip (LOC) is a device that integrates one or several laboratory
functions on a single chip that may be millimeters to a few square centimeters in size.
These devices are capable of handling extremely small fluid volumes - down to less than
picoliters. Lab-on-a-chip devices are a subset of Micro-Electro-Mechanical Systems
(MEMS) devices and often also called "Micro Total Analysis Systems" (!TAS). However,
the term ‘Lab-on-a-chip’ is more generic as these microfluidic systems are capable of
performing much more than just analytical functions.
The first LOC analysis system was a gas chromatograph, developed in 1975 [1].
During the next two decades, LOC research started to gain ground as scientists
developed concepts for microfluidic systems [2, 3]. Specific functional elements such as
flow sensors [4, 5], micro-pumps [6, 7] and micro-valves [8, 9] were developed.
1

Researchers started to construct highly integrated compact devices. Systems
demonstrated the inclusion of pre-treatment steps, usually done at lab-scale, thus
elevating their utility from simple sensory functions to complete laboratory analysis.
These devices have a wide range of applications. Chemists are using such tools
to synthesize new molecules and materials (rapid screening [10, 11], microreactors for
pharmaceutics [12]), and biologists are using them to study complex cellular processes
(e.g. biochemical analysis [13, 14], environmental monitoring [15, 16], medical
diagnostics [17, 18], cellomics [19, 20]). LOC devices are slowly becoming enabling
devices for research in fields such as genomics [21], proteomics [22],
pharmacogenomics [23] etc. These systems can offer point-of-care diagnostic abilities
[24, 25] that could revolutionize medicine.
The ability to perform laboratory operations on a small scale using miniaturized
devices is highly attractive [26]. Small volumes reduce the time taken to synthesize or
analyze a product. The unique behavior of liquids at the microscale allows greater
control of molecular concentrations and interactions. Reagent costs and the amount of
chemical waste can be much reduced. The compact size of units is a benefit in itself;
increasing deployment possibilities. Samples can be analyzed at the point of need
rather than a centralized laboratory. Massive parallelization due to compactness, allows
high-throughput analysis. Also they offer a safer platform for chemical, radioactive or
biological studies because of integration of functionality and smaller fluid volumes/stored
energies. Furthermore, benefits typical to MEMS systems also apply to these devices,
i.e. they have low fabrication and disposal costs, and are conducive to mass production.

1.2 Elements of Lab-on-a-Chip System
A typical LOC system contains multiple elements, active or passive. The
incorporation of most elements is application dependent, though some passive elements
2

are almost always required. Active elements may be micropumps [6, 7], microvalves [8,
9], heaters [27, 28], micro-sonicators [29], flow sensors [13, 14] among various others.
Passive elements may be microfluidic chambers [30-32], microfluidic channels [33, 34]
or other external interface elements.

Figure 1: Sketch of a prototypical LOC system [35]
3

Figure 1 shows a sketch of a typical LOC system. The system depicted consists
of multi-level functional layers integrated together. The development of such a system is
usually highly complex. There are numerous parametric dependencies at each design
level. An efficient system level layout and effective integration protocol is crucial, and so
is design optimization of each constituent element. Every element of the system needs
to be design as per the specific application requirements. Enhancement of any particular
element can lead to profound gains in various output specifications.

1.3 Systems for Biofluid Transport and Manipulation
In this research, LOC systems that specifically transport analytes through skin
and manipulate biofluids have been investigated. Examples of such systems include
LOC’s for heath monitoring or disease detection via biomarker analysis [36, 37], DNA
extraction [38, 39] etc. Different LOC systems might need to interact with skin directly to
perform varying tasks, such as, extract analytes, deliver therapeutic entities or extract
physiological signals. For example, an LOC might be a system for medical diagnosis;
analyzing biological entities, such as blood [40-42], extracted through skin. Other
possible applications may be recording and analysis of bioimpedance [43-45], or drug
delivery [46, 47]. Such devices would employ an external biotic interface. The specific
type and design of the interface would application dependant. They may be active
elements (microelectrodes for electroporation) or passive elements (microneedles for
biofluid extraction). Such systems promise to bridge the biotic (organism/skin) and
abiotic (environment) realms in unanticipated ways.
Currently accepted approaches to collect samples through skin include disruption
in skin structure through needle puncture, removal of the stratum corneum through gels
[48] or tapes [49, 50], or laser ablation followed by vacuum assisted extraction [51].
Micromachined electrodes and needles (microelectrodes or microneedles) can enable
4

collection of the same information, with significantly less trauma to the tissue, and have
the potential of even eliminating it [52, 53].
The microneedles, when incorporated into the LOC, will enable the development
of a generic front end to the micro-system. Such an interface can take care of most
applications involving skin interaction, whether diagnostic or therapeutic in nature. The
LOC sub-systems can be broadly classified by the type of entity transferred: physical
(fluid transfer) or electrical (charge transfer), and the system may incorporate any or
both types of interactions.
The LOC system may be either a stand-alone diagnostic or therapeutic system,
or have both capabilities. An active feedback controlled system in which the therapy
depends upon the diagnosis constitutes a ‘smart’ system. The data collected may either
be used locally or be relayed further; in which case the system would incorporate an onboard data communication capability; to transmit raw or significant data. Advanced
sensor systems would follow a node-based approach for a global level monitoring. They
shall include low power wireless communication protocols within multiple nodes,
distributed computing algorithms and protocols at these nodes.
The MEMS devices that interact with the skin would depend upon the application
and will generally be microfluidics based (for fluid transfer systems), or IC based (for
charge transfer systems). Fluid transfer systems can be expected to be more complex
and will have multiple component levels.

1.4 Lab-on-a-Chip Elements Under Investigation
This research aims to enhance the state of the art of LOC systems via
optimization and characterization of specific constituent elements. The first element is
the microfluidic chamber, which forms the most prevalent back-end element of a LOC
system. There are multiple design considerations that go into optimizing the microfluidic
5

chamber, such as material, functional and architectural. Common variables might be:
compatibility of building material with the application; deployment scenarios; number of
chambers required for desired reliability; type of fluid being handled (blood, ISF,
suspension of cells, specific chemical); etc.
The second specific element that has been studied is a typical external interface
– microneedles. As the term implies, these are similar to regular hypodermic needles,
except that they are much smaller. In the case of microneedle design all the material,
functional and architectural considerations that were there for microfluidic chambers still
apply. But there get added many more parametric interdependencies; the geometry of
the individual needle, the structural strength of the needles, biocompatibility, toughness
of the biotic layer being punctured, etc.

1.5 Manipulation of Biofluids in Lab-on-a-Chip Systems
Most LOC systems need to handle biofluids within microfluidic chambers.
Typically these chambers have no functionality other than being passive containers.
However, even this task needs careful design of the element. Material, functional and
architectural considerations exist. A major issue while handling biological fluidics is
biocompatibility.
‘Biocompatibility’ requirements vary as per specific applications. Generally, the
microfluidic chamber material should act as an appropriate host to the biological entities
for the application. There should not be any toxic or detrimental effects on the biofluids,
that might affect system efficiency. Continuous research is required to gain insight into
how biomaterials interact with the chamber body and eventually how those interactions
determine the success of the LOC device.

6

1.6 Interfacing Lab-on-a-chip Systems With Skin
The iterative development of noninvasive, bio-engineered lab-on-a-chip systems
should not ignore the body’s own exquisite material solution to biotic/abiotic interface
design. Seamless coupling to the body surface requires a better understanding of the
molecular architecture of the SC as a polymer film and the functional unit organization of
the epidermis. This challenge amounts to nothing less than a beginning understanding
of the boundary conditions of the human body. This will necessitate integration of broad
advances in a wide variety of fields viz. microsystems, clinical medicine, cell and
molecular biology, and information technology. Such extended interface systems would
be typically freestanding, multifunctional, multimode, microfluidics-based sensor systems
coupled to human skin for real time monitoring at global (physiological) and local
(molecular) levels.

Figure 2: Bioengineered interface between analogous biological and LOC systems [35]

The scope of systems containing bio-engineered micro-interfaces goes beyond
sampling and extraction of high-quality distributed physiological data. Advanced systems
hold the potential to incorporate both diagnostic as well as therapeutic functionality.
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Such systems would utilize information in the same manner as the body uses the skin
surface for sensorimotor feedback control [54-60].
Development of bio-engineered skin-interfacing LOC systems require
interdisciplinary research combining such diverse fields as tissue engineering, molecular
biology, anatomy, physiology, medical physics, biology, mechanical engineering,
microfluidics, chemical processes, microfabrication, nanotechnology, and signal
processing.
When a foreign object is introduced in the body, the body rejects it by forming
scar tissue around it, thus isolating it from the rest of the body. An interface between the
sensing system and the skin needs to ‘ensure that the body does not initiate this defense
mechanism. Such ability would make it possible for the interface material to act as a
seamless bridge that performs transfer of signals and samples to the sensing system.
Systems with such interfaces would have the potential to integrate detection,
diagnostics, and treatment of adverse medical and physiological states affecting the
human body. An example of major drivers for such systems is diabetes. There are
numerous active efforts underway to develop a seamless glucose sensing and insulin
delivery systems that can function over extended durations. Other systems could enable
diagnosis of adverse states like heat prostration, exhaustion, dehydration, hemorrhagic
shock, and anxiety. This approach can potentially result in physiologically and clinically
relevant information far in advance of changes in central measures like blood pressure,
arterial blood gases or acid-base status.
Positioning sensors strategically on the body surface and incorporating
developments in Computer Science and Engineering viz distributed computing
algorithms, and low power wireless communication, can allow observation of the target
biological processes in the body in real time, similar to electrocardiography and
electroencephalography. Essentially, the bio-engineered interfaces will facilitate (a)
8

characterization of the quantitative boundary conditions of the human body; (b)
determination of variation of those conditions with disease and environmental change,
and; (c) putting into effect suitable therapeutic response, as needed.

1.7 Anatomy of Skin
The research entails focus on the unique biological boundary of the body
manifested by the surface of the human skin. Specifically, attention is drawn to the
outermost layer of the skin, the stratum corneum (SC), which, as the terminally
differentiated (dead) product of epidermal differentiation forms the ultimate biopolymeric
interface with the environment. The SC, viewed through the lens of a materials
engineer, is a multifunctional nanocomposite with all the hallmarks of a smart material.
The strategic location of this highly organized, thin (~20 µ), bioengineered film place it in
an optimal location to mediate biotic/abiotic interactions. Improved sensor systems for
noninvasive detection of physiologically relevant mechanical, electrical, or magnetic
signatures at the surface of the body (data beyond current electrocardiography or
electroencephalography) require bridging to the body via this complex but assessable
biological structure.
To develop a long lasting interface, the nuances involved in interfacing with skin,
need to be understood. Towards that goal, a brief review of the skin is provided
hereunder.
1.7.1 General Structure
Skin is the largest organ of the human body and accounts for approximately 16%
of the body weight. It serves multiple purposes which can be broadly classified into four
functions – 1) Protection: physical, biological, against UV light, from dehydration; 2)
Thermoregulation: control of body temperature 3) Metabolic functions: synthesis of
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vitamin D, excretion of waste products, storage of fat; 4) Sensory functions: pressure,
heat, cold, contact, pain, as well as integral interaction with vision (pigmentation
patterns) and smell (pheromone release). It is evident from its range of functionality that
the skin hosts complex physiological, biomechanical and biochemical processes, all
occurring simultaneously.

Figure 3: Cross-section of skin [61]

The skin possesses a layered structure comprising of various kinds of tissues. It
has two layers, the dermis and the epidermis. The epidermis is the outer layer of the
skin. Being a tough and waterproof layer, it protects the inner regions. The underlying
dermis is a thicker layer and is responsible for imparting strength and elasticity to the
skin. Beneath the dermis is the subcutaneous layer, which is not part of the skin itself. It
is a layer of tissue made of protein fibers and adipose tissue (fat). It contains glands,
sensory receptors and other skin structures.
The protection provided by the epidermis forms the first barrier against harmful
foreign substances. Most of the cells (approximately 90%) in the epidermis are
“keratinocytes”. They produce a tough, fibrous, intracellular protein called keratin; hence
the name. The keratinocytes are stacked in layers. The youngest cells occupy the lower
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layers while older cells are present in the upper ones. The lower layer cells multiply
continually, while the older upper layer keratinocytes constantly slough off. By the time
the cells move up to the uppermost layer of the epidermis, they are dead and completely
filled with the keratin. From bottom to top the layers are named stratum basale, stratum
spinosum, stratum granulosum, and stratum corneum.

Figure 4: Cross-section of epidermis [62]

Various skin properties are routinely measured at the broadest classification level
whereby considering the entire epidermis as a single functional entity. Such information,
though essential, is incomprehensive in that it does not account for the heterogeneity of
the epidermis. It is imperative to possess precise knowledge of the distinct properties of
each cutaneous component to design interfaces that interact individually with the cuticle
layers. The stratum corneum in particular dominates various design considerations and
is often times the principal cause for development of micromachined interfaces.
1.7.2 Stratum Corneum
The outermost layer of the epidermis, the stratum corneum (SC), is a thin,
flexible, high impedance biopolymer composed of interconnected ‘dead’ cells called
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corneocytes. This complexly organized, anucleate, 15-20 µm thick, biopolymeric
structure is essential to life and serves to couple the organism to the environment. This
structure is particularly well developed in humans who lack a protective mantle of fur. It
is the major barrier to all environmental insults (climatic, toxic from xenobiotics or
microbial) [63]. Despite its resilience it can bind a certain amount of water to stay soft,
smooth and pliable even in a dry environment, thus allowing free body movement
without cracking or scaling of the skin surface.
The underlying hypothesis in the development of bio-engineered systems is that
the stratum corneum can be a portal to the biological and physiological processes. It
plays a major role in modulating sensory signals for visual and tactile perception. Also,
the hydration status of the stratum corneum is a key determinant of the mechanical,
electrical, optical, and chemical properties of the skin. The properties of this layer serve
as a health status indicator and valuable insights into the human biosystem can be
attained by characterizing the quantitative boundary conditions of the human body and
determining variation of those conditions with disease and environmental change.
As a secondary consideration, the condition of this layer serves vital social and
cultural functions as it is a major determinant of our appearance and is thus of central
interest to the cosmetic industry. The multifaceted significance of the stratum corneum
necessitates a multidisciplinary approach towards its analyses. Current researchers
include dermatologists, cosmetic scientists, physiologists, neonatologists,
pharmaceutical scientists and bioengineers.

1.8 Designing a Lab-on-a-Chip System
Despite architectural differences, the tasks involved in designing the LOC
systems have certain standard objectives. These objectives establish the foundation of
knowledge and capabilities required to build the specific system. They include: (a)
12

understanding the cellular and molecular biology of the biofluid being handled; and (b)
developing tools, techniques and protocols to non-intrusively or semi-intrusively collect
relevant physiological information using an array of micro/nano probes, sensors and
analysis protocols. For a global level system it includes: (c) using distributed computing,
imaging and wireless communication to analyze, correlate and understand the response
of the skin at various body sites to a single controlled stimulus and across a group of
sensors at a population level. Fluid transfer systems entail: (d) developing models to
understand microfluidic coupling between the stratum corneum and MEMS-based tools
and on-chip immunoassays and sensors. Therapeutic systems include: (e) developing
therapeutic application methodologies and protocols to deliver required medication
based upon computational algorithms.
Each of the objectives mentioned above encompasses numerous tasks, which
involve of varied undertakings in biology, medicine, chemistry, information technology
and microtechnology. The first task includes interface testing on various microfluidic
chamber surfaces. Relevant target measurements on skin such as bio-impedance,
immunoassay and analyte detection would have to be conducted. This would assist in
identifying key analytes to be monitored, and determining the baseline and deviation
standards. Information/models and images would be used to enable extrapolation of
data from the tissue level microenvironment, to an understanding of meaningful
physiological responses at the level of the organism. For reagent analysis systems,
immunoassays and analyte detection protocols have to be developed. Sensor/analyzer
designs have to be built accordingly by the MEMS designers. Deciding upon the
physical design and establishing fabrication procedures of the individual LOC elements
would form the most vital component of system development. The biggest challenge
would lie in integration of the various microdevices (such as the passive microfluidic
components, sensors, active elements etc.). To ease the development process, the LOC
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systems can be expected to have a modular design, i.e. each sub-system would be
functionally independent. However sub-system development cannot be independent of
other tasks and continuous collaboration between MEMS and biotechnology/information
technology groups would have to be a standard feature of the design process.
If an LOC is expected to be autonomous, the information technology tasks could
include development of data processing capability and a data transfer interface.
Depending upon whether the LOC unit is a stand-alone node or part of a global sensing
system, the tasks would include creation of low power wireless communication protocols
within multiple nodes, distributed computing algorithms and protocols at these nodes,
and transmission of raw or significant data collected from individual nodes. Data
management tasks would comprise of signal conditioning, post processing, sensor
fusion, and feedback control to manage and optimize the device/skin interface. Data
depiction front-ends would have to be created to facilitate easier data interpretation, e.g.
providing the data as a 3-D image composite.

1.9 Designing the Lab-on-a-Chip Elements
Element design is a critical part of designing an LOC system. It involves
simultaneous consideration of multiple parameters. There is always present some form
of trade-off. In case of microfluidic chambers, an example would be non-specific DNA
binding vs. ease of fabrication, life span vs. ease of integration etc. For microneedles,
such considerations would be ease of skin penetration vs. ease of fluid flow, probe
strength vs. biocompatibility etc. There is no specific optimum design; it varies with each
application. The combinatorial possibilities are vast and the parametric interdependency
highly complex. Every application will have a few structural or functional demands that
bear higher priority than others. Fortunately, not every application needs a new needle
design. Most applications can be grouped into classes having broadly similar
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requirements. Thus generic element arrays can be designed with specifications that
provide enough latitude for parametric variations within the class.
1.9.1 Functional Requirements of Microfluidic Chambers
Interface elements in LOC devices have to satisfy diverse functional requirements.
Microfluidic chambers don’t have to usually satisfy strict mechanical requirements. Their
most significant requirement is biocompatibility with the biofluids. Non-specific binding is
an inherent problem. Biological entities adhere to surfaces that they are not supposed to,
and detach when not supposed to. Thus non-specific binding may interfere with the
obtained output, and reduces the overall sensitivity. Efficient cleaning of the microfludic
chamber suddenly becomes a top priority is many times not a trivial task.
1.9.2 Functional Requirements of Microneedles
In the case of microneedles, a large majority of requirements are mechanical in
nature. Bioengineered interfacing entails insertion of microneedles into the upper
epidermal layers of the skin, and thus the probes have to be able to withstand the
applied pressure and puncture the skin without fracture. Optimum design demands
characterization of various mechanical features such as mechanical strength, buckling
characteristics, fracture point, elasticity, angular strength, ease of penetration etc.
Microneedles have to be further characterized for their capability to withstand fluidic
pressure at the sidewalls and the inlet pressure for a particular flow rate.
. This requirement is imposed on the needles too, with regards to their interaction
with skin. Interaction of non-biocompatible needles with cells and tissue is known to
trigger “foreign body response” and cause bio-fouling. Biologically, such a system
constitutes a breach in the integrity of the organism and would be responded to as a
wound. Thus it becomes difficult to determine whether one is sampling "intracellular"
fluid from impaled cells or "extracellular" fluid from needles placed between cells. The
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most common approach to minimize biofouling is surface passivation of the functional
materials.
Microfluidic properties of microneedles are also important design factors. The
design has to take into account fluid flow characteristics for the passing fluid and also
environmental flow resistance. There should be no clogging of the fluid at orifices or
along the needle lumens. Also capillary forces have to be sufficient to ensure fluid
delivery or extraction.
Other common parameters affecting microneedle design include adhesive
interactions (adhesion of analytes to the needle), life duration, chemical inertness and
biodegradability.

1.10 Design Variables for Lab-on-a-Chip Elements
Common variables that control the component characteristics can be broadly classified
into: 1) Material selection 2) Geometric considerations 3) Array layout
1.10.1 Material Selection
There is no one best material available for the fabrication of microfluidic
chambers or needles. The choice varies according to the application.
In the case of microfluidic chambers, polymers such as polydimethyl siloxane
(PDMS) [64], polymethyl methacrylate (PMMA) [65] are highly popular due to their ease
of fabrication. Plastics derivatives like polycarbonate [66] and cyclic olefin copolymers
[24] are also popular due to the cost benefits.
Metallic needles [67-69] are popular due to strength and biocompatibility; they
have lowest probability of causing allergic reactions. However, the minimum size of
needles possible is relatively large. They are relatively easy to fabricate; common
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methods being micromolding or electroforming, Stainless steel is used quite often due to
its high strength, non-corrosive nature and low price.
Non-metallic materials have other advantages. Glass microneedles [70] provide
ease of fabrication while silicon dioxide microneedles [71, 72] offer good biocompatibility
characteristics. Polymer microneedles [73-75] are of interest since they are
biodegradable. These microneedles can be used without danger of infection due to
needle tips breaking off. Conductive polymers are often used for microelectrodes due to
their selective interaction properties with proteins, enzymes and antibodies thus making
them ideal for certain biochemical sensing applications. Furthermore, polymers are
highly flexible too. The most common and prevalent material for microneedles is silicon
due to high strength, design flexibility and ease of fabrication [76-79].
1.10.2 Geometrical Considerations
Geometric considerations for microfluidic chambers are dependent upon the fluid
being handled, its viscosity, Reynolds number and Newtonian characteristics among
other things. The specific application and the employed protocol determine the size and
arrangement of the chambers.
Geometry of the microprobe affects most of the electrical, mechanical or other
characteristics highlighted earlier. Common geometrical considerations are needle
length, width, area/perimeter of cross-section, shape, thickness of sidewalls, tip
geometry, taper angle, etc.
Each geometrical variable can affect a number of parameters and thus the
optimum choice of geometry is often a trade-off between efficiencies. For example,
sharper needle tips can be expected to require less force for insertion, but the reduced
penetration force comes at the expense of reduced strength near the tip [80].
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Needle length determination is particularly critical as the needles must be
sufficiently deep to allow reliable test results, and for drug delivery or sample extraction,
they have to reach the blood capillaries. The possibility of fracture and buckling increase
as probe length increases. Also, in order to be painless, the needles cannot be so long
as to touch the nerve endings. Increasing cross-sectional area increases strength but
may compromise certain insertion force into skin. Constriction of needle lumen size is
limited by the size of species being transferred. Finally, biofouling properties always
impose critical constraints, it being less intensive for less invasive geometries.
Microneedle are most often used in an array formation. Thus device functionality
depends upon the not only on their individual, but also on their ‘team’ efficiency. Array
size, density and configuration are most important considerations. A very closely packed
array can cause unsuccessful penetration due to ‘bed of nails’ effect [81].

1.11 Technological Merit of Skin Interface Elements
Micromachined needles form the technological foundation for bio-engineered
skin interfaces for the LOC devices. The physical characteristics of microneedles provide
unique technological advantages to these systems as compared to traditional invasive
methodologies. Next generation therapeutic methods using advances in genomics,
proteomics, pharmacogenomics etc., have all come into existence due to the capabilities
provided by these micro-components.
Tissue interaction is usually done using macroscale components such as
hypodermic needles (henceforth referred to as macroneedles). Such components offer
immense utilitarian advantages in their being easy to fabricate and handle. They are
irreplaceable in appropriate problem identification and drug delivery applications that
warrant the use of large sized interface tools. However with the advent new technologies
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and discoveries, these conventional tools are being fast replaced with their
micromachined counterparts.
1.11.1 Benefits From Microneedles
In typical clinical and biomedical applications, drug injection or biofluid sampling
is done using hypodermic needles. Though utilitarian, this method causes undesirable
pain and excessive tissue trauma. This is particularly troublesome when frequent
administration of drugs is necessary (such as administration of insulin). Furthermore,
control of drug delivery is highly approximate using macroneedles.
A painless alternative to macroneedles, which has lately started to become
popular, is the transdermal patch. It is simply a piece of plastic with an adhesive on it
with the drug being suspended in the adhesive. The patch is stuck on the skin and the
drug passively diffuses slowly to lower layers. However, this method of drug delivery
poses certain challenges. The effectiveness of the adhesive is directly affected by the
concentration of the drug within the adhesive. Thus, if a larger dose of the drug is
required, either it has to be reapplied more frequently or a larger patch has to be used.
Increasing the concentration of the drug does not help if the adhesive bond with the skin
is weak [82]. Furthermore, it is a slow method and not very precise, and is thus not
suitable to many applications. The barrier properties of the stratum corneum pose
unique obstacles to drug application by providing for a very low topical bioavailability
[83]. The “route” taken by the externally applied drug is tortuous – around the dead,
dense corneocytes. The permeant diffuses in the intercellular channels, which contain
structured lipid bilayers. Thus the problem is compounded, as molecules have to cross,
sequentially, lipophilic and hydrophilic domains.
Microneedles are increasingly being sought out as an alternative to the
macroneedle and the transdermal patch as it combines their advantages while
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eliminating the disadvantages of both. In recent times, numerous types of micro needles
have been fabricated and used for transdermal drug delivery [84-88], vaccine delivery
[89], fluid analysis and sampling [90], dialysis [91] and cellular DNA delivery [92] among
other applications.
Vital technological advantages obtained by using microneedles are:
1.11.1.1 Increased Permeability
The self-sealing properties of the stratum corneum are poorly understood. It is probable
that the stratum corneum seals holes spontaneously up to a given magnitude, but
beyond that limit it cannot close itself. This property can be used by microneedles to
increase the permeability of skin by orders of magnitude, making it is possible to diffuse
macromolecules across the skin. Thus in some cases, the microneedles may not
themselves deliver the drug. Unmedicated microneedles may simply puncture the skin
and then medicines may be smeared on and left to be rapidly absorbed through the
holes.
1.11.1.2 Application Customization
Microneedles can be fabricated in various shapes (cylindrical, pyramidal, polyhedral,
etc.) or sizes and may be hollow or solid. Such geometrical flexibility allows for
fabrication of microneedle arrays customized for the type and volume of drug and the
duration of use. This feature also translates to flexibility in method of drug delivery. For
example, medicines may be delivered the way a regular hypodermic needle does so, or
microneedles may be coated with medication which would be absorbed on contact.
1.11.1.3 Material Flexibility
Microneedles can be fabricated using a variety of materials such as silicon, glass,
carbon nanotubes, biodegradable polymers, and metals. The choice of material would
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depend on the application. For example, metallic microneedles are the most popular
because they have high strength and biocompatibility. Polymer needles have the
advantage of being biodegradable and thus if the tips snap off during insertion, the body
would simply absorb the remains.
1.11.1.4 Minimal Medical Training Requirements
Microneedles are expected to become a boon for immunization programs in developing
countries as they could be applied by people with minimal medical training. Drugs could
similarly be administered at home instead of presently compulsory clinical visits. The
significance of such capability is further enhanced due to possibility of mass vaccination
or antidote administration in bioterrorism incidents. The cause is further helped by the
fact that microneedle fabrication promises to be less expensive than any other reported
technology.
1.11.1.5 Site Specific Therapy
Highly targeted drug administration to individual cells is possible using microneedles. A
potential application is to modulate the immune system by administering drugs precisely
into the area where special immune cells reside. Langerhans cells, for example, are the
major immunomodulatory cells which modify delivery of HIV particles from the epidermis
to the lymph nodes - these cells are located only 40-50 microns deep in the epidermis.
Vaccine delivery directly to these cells provides a target of mass vaccination strategies.
1.11.1.6 Precise Control of Drug Quantities
The small volumes of drug passing through the microneedles, either through diffusion or
through auxiliary pumping systems make the delivery process highly controllable.
Microneedles are presently at various stages of development though they are yet
to be introduced clinically. They will surely revolutionize drug delivery systems and
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provide more options and possibilities to patients. The day is not far when administering
of polypeptides and even proteins will not be via injection or infusion.

1.12 Microneedle Design for Autonomous Therapy Systems
As mentioned earlier, an application-independent optimum design for
microneedles does not exist. Design selection is highly application specific and involves
simultaneous consideration of multiple parameters. Common design variables include
geometric features (length, diameter, shape), choice of material, array layout, physical
architecture (beveled tip, conical, side-opened) etc. There is always a trade-off among
the various output characteristics such as fragility, biocompatibility, penetration force,
fluid flow rates, ease of fabrication, cost etc. Application specific requirements of
diabetes therapy systems necessitate that certain microneedle characteristics have
higher priority. Key design issues and related parametric interdependencies specific to
diabetes therapy systems are discussed below.
1.12.1 Microneedles for the Sensing Component
Glucose sensing can be done by sampling either blood or interstitial fluid (ISF).
The choice of the biofluid sampled is the primary factor determining microneedle design.
In order to understand design variations between blood extracting microneedles and ISF
extracting microneedles, it is important to understand physiological differences between
blood and ISF.
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Figure 5: Relative insertion depths of microneedles [46]

1.12.1.1 Microneedles for Interstitial Fluid Sampling
The depth of microneedle penetration needs to be in the approximate range of
50–150 !m to extract ISF. Such low microneedle height requirement translates to higher
latitude in design variations. Microneedles have two possible failure scenarios - fracture
or buckling. In general, shorter needles, of the same diameter and material, can
withstand higher pressures without failing. Thus, needles composed of relatively lower
strength material, e.g. silicon dioxide, can be used for ISF sampling. Silicon dioxide is
also highly biocompatible, an additional advantage. Reduced height allows for smaller
needle diameters without inducing buckling [93]. A smaller tip diameter results in a much
higher ratio of fracture force vs. insertion force into skin [94]. This increases the margin
of safety for employing microneedles without failure. Microneedle lumen diameters for
ISF sampling can typically be as low as 10 !m.
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A small microneedle diameter coupled with the low density of ISF induces
extremely high capillary forces. Capillary forces also increase with higher hydrophilicity
of the microneedle material. This facilitates extraction of the fluid even without a
pumping mechanism. Unfortunately, the flow rate through microneedle declines with
decreasing diameter [95]. Thus, an initial latent time exists before the microneedles are
filled with ISF [96].
Glucose sensing is a good example of ISF extraction, can serve as a model for
general volumetric analysis. Most commercial ISF glucose sensors require around 0.5!l
– 2!l of fluid [97], and this figure is continuously decreasing. In order to increase flow
rates, an array of microneedles is used to achieve the required flow. Vacuum pump
assisted ISF sampling using microneedles in humans has been demonstrated and
shown to successfully track changing glucose levels following insulin injection with a
time lag of less than 20 minutes [98].
1.12.1.2 Microneedles for Blood Sampling
Blood capillaries are present just below the epidermis. Generally blood
microcapillaries are found at penetration depths of about 400 !m. The nerve tips are
also present in the same depth vicinity. Thus some microneedles within the array might
just graze the topmost nerve cells. However the extremely small diameters and
controlled shank length reduce the odds of encountering a nerve or of stimulating it
enough to induce pain [99, 100]. Figure 5 depicts the relative insertion depths of
microneedles used for blood or ISF sampling.
In order to extract blood without significant pain, microneedle shank lengths need
to be around 400–900 !m. At these lengths the microneedle needs to be built using
higher strength materials such as metal or silicon. A common model used by
researchers is the dimension of the female mosquito proboscis [40, 42]. The
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microneedle diameter needs to be large enough to allow convenient passage to the
largest blood cells. Also, the larger length necessitates larger diameters to preclude
needle failure via buckling. Typical microneedle diameters have to be at least 50 !m
wide. Even though capillary action alone can be enough to extract blood, factors such as
higher fluid density, larger conduit diameter, and the material of choice can mitigate the
effect. In such a case, a microfluidic pumping device is needed to generate negative
pressure [42].
1.12.2 Microneedles for Drug Delivery
For fluid infusion, flow rates of greater than 1ml/hour for a single microneedle
have been demonstrated [101]. Even with modest rates, and employing a needle array,
requisite amount of dosage can be easily transferred via microneedles.
1.12.3 Fluid Flow Through Microneedles
Deciding the microneedle array specifications (pitch, size of array) is as important
as design of the individual microneedle. Microneedles can sometimes get clogged by
tissue being trapped in a needle lumen during insertion (beveled-tip [102] or side-opened
[103, 104] needle designs minimize these effects). Employing numerous needles
minimizes the influence of individual needle failures or passage blockages. Also, as
mentioned earlier, use of an array formation increases fluid flow rates. The flow rate
increases linearly with the number of microneedles in the array. However, care has be
taken not to place needles too close to each other, otherwise a ‘bed-of-nails’ effect can
result in the skin being pushed down uniformly without penetration [81]. Generally
microneedles are placed more than 200 microns apart and array size can be as small as
a few microneedles to hundreds.
Fluid flow through a microneedle is generally assumed to be laminar. It largely
depends upon the pressure difference across the needle and is set by the microfluidic
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pump and the capillary forces. Unfortunately, a fluid-mechanical description of the skin
has not been established yet, and thus modeling flow through a microneedle is a
complex task; complicated further by the fact that biofluids generally exhibit nonnewtonian behavior. Various non-linear in-vivo effects such as liquid absorption in the
epidermis, hindrance to fluid motion due to presence of cells and saturation play a role in
fluid dynamics. Furthermore, there are present pressure losses due to flow down a
microneedle. These can be attributed to entrance losses, drag on the duct walls, and
losses due to specific microneedle geometry (expansions, bends, etc.) [105].
Basic modified Bernoulli equation is often used as an approximation to model
fluid flow.
1)
"p is the pressure drop, q is the flow rate, K1 and K2 are macroscopic values that
represent inertial minor losses in piping systems, ! is the density of liquid, µ is the
viscosity, D is the diameter of needle and L is the length.
The Hagen-Poiseuille Equation, which describes slow viscous incompressible
flow through a constant circular cross-section, is generally used to establish rough
estimates.
2)
For n microneedles the net flow rate gets multiplied by a factor of n.

1.13 Contribution to State-of-the-Art
This research intends to make the following contributions to the state-of-the-art in
lab-on-a-chip devices:
1) First study on DNA binding analysis on microfluidic chamber materials.
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2) Novel use of microfluidic chamber as an active element within a lab-on-a-chip
device.
3) First reported fabrication of hollow microneedles with sharpened tips.
4) First reported study on shear fracture of microneedles.
5) First reported study on strength testing of silicon dioxide microneedles.
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CHAPTER 2
BACKGROUND

Advanced lab-on-a chip systems have the potential to close the loop between
diagnostic and therapeutic elements of diabetes treatment, thus constituting a ‘smart’
system [106]. A microfluidic device consists of various passive and active components.
Active elements may be micropumps [6, 7], microvalves [8, 9], heaters [27, 28], microsonicators [29], flow sensors [13, 14] among various others. Passive elements may be
microfluidic chambers [30-32], microfluidic channels [33, 34] or other external interface
elements such as microneedles. Each of the components of a microfluidic device needs
special attention to enhance their individual properties. In this research, microfluidic
chambers as well as microneedles have been studied as components for a typical labon-a-chip device.

2.1 Enhancement of the Microfluidic Chamber: Material Considerations
2.1.1 State-of-the-Art in Microfluidic Chamber Material Research
Various chamber materials have been studied individually in research literature.
Most commonly ‘soft’ materials such as PDMS and PMMA are used to form microfluidic
chambers, and their properties have been extensively studied [30-32]. Recently there
have been studies on large scale integration of materials to form lab-on-a-chip device
[107, 108].
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However, there hasn’t been any comprehensive study on the relative properties
of materials with respect to microfluidic chambers. This research aims to fill this gap in
scientific literature.
2.1.2 Lab-on-a-Chip Systems for DNA Extraction
LOC systems are routinely used for applications involving DNA extraction from
biological cells [38, 39]. A popular application of this type is chromatin
immunoprecipitation (ChIP) [109]. ChIP is a recently developed laboratory method that is
useful for analyzing modifications to chromatin, investigating gene expression,
identifying transcription factor binding, and identifying unknown genes of transcription
factors. All of these have relevance to understanding the biology of cancer. This type of
immunoprecipitation has been used with increasing frequency in research applications
over the past 10 years. Chromatin immunoprecipitation protocols (ChIP) also have
potential for use as an early detection method for cancer.
The ChIP process is essentially a protein-DNA binding protocol. The process
involves formaldehyde crosslinking of proteins to DNA in intact cells, followed by
extraction of protein-DNA complexes via cell lysis. Subsequent biochemistry steps such
as antibody binding, reverse cross-linking and protein digestion result in extraction of the
target DNA. It is imperative that the surfaces on which the reaction is performed are
thoroughly cleaned after each step because the presence of any DNA impurity in the
final product is amplified during analysis. This necessitates that the microfluidic chip be
made of materials that show the lowest non-specific binding of DNA through the entire
processing cycle. When not bound (or loosely bound) to the chamber surface, the DNA
impurities can be easily washed away to a waste chamber. Desirable washing
characteristics like these make the whole process faster, more efficient, and result in
higher purity output.
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A material with attractive properties for use as a base material in microfluidic
devices is nanocrystalline diamond. Its chemical inertness, optical transparency [110],
and high thermal conductivity make it suitable for incorporation with both active and
passive devices, such as channels, mixers, reaction chambers, pumps, heaters, and
sensors for measuring temperature, flow, impedance, pH, etc [111]. Various microfluidic
structures have been built using crystalline diamond [112-114]. Researchers have
functionalized diamond films for various kinds of biological sensing applications [115120]. However its value towards specifically biological lab-on-a-chip devices hasn’t been
fully exploited. Nanocrystalline diamond’s surface smoothness correlates to it being an
excellent chamber base material for biological entities such as proteins, DNA, cells, etc.
Nanocrystalline diamond when terminated with hydrogen is a highly hydrophobic
material, and its hydrophobicity can be controlled by post-deposition processes [121].
Consequently, it resists non-specific DNA surface binding. This property is significant to
biological lab-on-a-chip applications such as chromatin immunoprecipitation.
Researchers have shown favorable DNA preservation or DNA attachment properties of
functionalized crystalline diamond [122-124]. These properties coupled with low nonspecific DNA binding demonstrated here enhance nanocrystalline diamond’s potential in
DNA handling applications.

2.2 Microfluidic Chamber as an Active Element: Enhancement of Cell Lysis
2.2.1 State-of-the-Art in Cell Lysis on Chip
Microfluidic chambers usually behave as passive fluid “containers”, with little or
no active role in device performance. However, for an application such as cell lysis
within a lab-on-a-chip, the microfluidic chamber can be modified to act as a “mechanical
catalyst”.
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Cell lysis is a common procedure in microbiology protocols that requires specific
implementation in a microfluidic lab-on-a-chip application. Cell lysis in a traditional
laboratory is typically done mechanically via ultrasonic vibration. This physical method
has the advantage that it does not require the use of chemical agents which reduces the
washing in the chip. Ultrasonication has also proven to be highly effective for
fragmenting DNA and is thus a more efficient lysis method for PCR [125] as opposed to
electroporation which is another commonly used lysis method. Nevertheless, microfluidic
lab-on-a-chip applications use chemical lysis [126] or electric fields [127, 128] for cell
lysis in most cases rather than a micro-sonicator [29]. This in part is due to the inherent
power limitations of an ultrasonic microresonator which limits the efficiency of cell lysis.
One solution is to employ disruption microbeads that are introduced in the cell
suspension to assist mechanical cell lysis [129]. These beads physical pound the cells
during sonication rupturing cell membranes. Unfortunately, having loose mechanical
entities in the microfluidic chamber results in complications. The beads may block the
microfluidic channels, and their introduction into the chamber is a cumbersome task.
This research explores the use of micro-spikes on the microfluidic chamber walls
to enhance cell disruption. During ultrasonication the cells collide against the chamber
walls. During this collision, the array of spikes physically puncture the cell walls
increasing the efficiency of cell lysis.

2.3 Microneedle Based Skin Interface Systems
2.3.1 State-of-the-Art in Microneedle Design
A critical design parameter in the fabrication of microneedles is the compromise
between structural rigidity and ease of penetration. Due to elasticity of skin, a
considerable amount of deformation takes place around the insertion site, significantly
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reducing the insertion depth of microneedles [130]. The outermost layer of the
epidermis, stratum corneum, is a thin, flexible, high impedance biopolymer composed of
interconnected dead cells. This layer is the major barrier to various environmental insults
(climatic, toxic from xenobiotics, or microbial), and needs to be punctured for fluid
transfer. Below the stratum corneum lies the viable epidermal layer that is devoid of
blood vessels and contains very few nerve endings. The thickness of stratum corneum
and viable epidermis of typical human skin are 10-40 !m and 50-100!m respectively
[131, 132]. These layers tend to deform rather than puncture upon needle incidence.
To mitigate the undesirable effects of skin deformation, the pressure applied by
the needle tips needs to be increased. Insertion pressure can be increased by raising
the applied force, or, by increasing the needle sharpness. An increase in applied force
intensifies the strain on the microneedles and may cause undue breakage. Furthermore,
it may also magnify the patient’s discomfort. Vibratory actuation has been suggested to
decrease the force required for insertion [133]. However, this requires the use of a
vibratory actuator, which may not be possible for all applications, or might complicate the
design requirements.
Permeation of microneedles can also be improved by increasing their sharpness.
However, this is quite often achieved at the expense of structural rigidity. The needles
must be capable of tolerating stresses related to the non-uniformity of skin contour,
inadvertent slippage during insertion or removal, and reasonable human movements
during period of penetration. Microneedles with extremely sharp tips, but thin needle
bodies have been employed with successful penetration into skin [134]. However,
structural damage after insertion was reported, as can be expected due to compromised
sidewall thickness.
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2.3.2 State-of-the-Art in Silicon Dioxide Needle Fabrication
Silicon dioxide being highly biocompatible is a potentially desirable material for
microneedle fabrication. Silicon dioxide allows for the smallest size of needles possible,
as compared to any other material. These needles are fabricated by etching silicon
followed by wet oxidation [71, 72].
Traditional fabrication methodologies employ lapping of bulk silicon, which
dramatically reducing the obtainable length of microneedles. Also, lapping is a harsh
process, and usually results in an uneven or sloping surface. This research involved
fabrication of silicon dioxide microneedles using silicon nitride as an etch–stop layer for
DRIE. The same nitride layer acts as an oxide barrier. This novel use of silicon nitride
results in no loss of the bulk silicon.
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CHAPTER 3
DNA BINDING STUDIES ON MICROFLUIDIC CHAMBER

The goal of this task is to analyze DNA binding to nanocrystalline diamond films.
Binding experiments were tailored specifically for chromatin immunoprecipitation
protocol. However results are universally pertinent for other biological microfluidic
applications. DNA binding tests were performed on nanocrystalline diamond samples
and compared with common building materials. These materials were silicon, silicon
dioxide, Polydimethylsiloxane (PDMS), Poly methylmethacrylate (PMMA), SU-8, and
glass.

3.1 Materials and Methods
3.1.1 Substrate Sample Preparation
In this study, DNA binding was tested on seven materials. Substrate materials
such as silicon (250 micron, (100), n-type, 10-30 ohm-cm, double side polished) and
glass (250 micron, Corning 7740) were used as is. Other materials were prepared on
similar silicon substrates. All materials were deposited on both sides of a silicon wafer to
ensure similar DNA binding on either side. The following parameters were used –
PMMA: 3000 rpm, 30 second spin, cure at 180 °C for 5 minutes; PDMS (Sylgard 184):
3000 rpm, 30 second spin, cure at 150 °C for 30 minutes; SiO2: dry oxidation at 1100 °C
for 6 hours to give 3000 Å oxide; SU-8 (Series 50): 4000 rpm, 30 second spin, soft bake
at 65 °C for 6 minutes followed by cure at 95°C for 20 minutes. Nanocrystalline diamond
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was grown in presence of Ar (371 sccm), CH4 (4 sccm) and H2 (25 sccm) for 6 hours
(750 °C, 95 torr, 800W RF power). It is well known that nanocrystalline diamond grown
in high percentage of hydrogen results in a natively hydrogen terminated surface. The
hydrogen termination results in negative electron affinity at the diamond surface,
imparting hydrophobic properties.
All seven types of samples were finally diced into equal sized squares of 6mm x
6mm to ensure equal area of exposure to DNA.
3.1.2 DNA Binding Protocol
The source of DNA for all experimentation was HeLa S3 (human cervical
carcinoma) cells. All tests to expose the substrates to DNA were carried out in
polypropylene tubes. Substrate material samples were separated into batches; each
batch containing one piece of each type of substrate. Then, a chromatin
immunoprecipitation protocol was performed in the presence of each substrate material
(approximately 2x106 cells for each ChIP) in order expose them to DNA. Nonspecific
DNA binding was tested after each of the three major steps of ChIP (cross-linking,
sonication, and immunoprecipitation).
The first few experiments were simultaneously performed in the presence of
extra DNA from a plasmid carrying the specific DNA sequence to be analyzed. This
extra DNA was used to amplify the response and provided verification of the results.
The following protocol was performed for each of the ChIP steps.
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Figure 6: DNA binding after crosslinking

3.1.2.1 Crosslinking
Seven identical tubes were prepared. Each contained two samples of a
particular substrate along with a suspension of cells. Crosslinking was performed by
adding 1% formaldehyde (in phosphate buffered saline (PBS), pH 7.4) at room
temperature. The samples were incubated for ten minutes while being rotated
simultaneously in a mixer. This ensured uniform distribution of DNA on the surfaces.
Crosslinking was stopped using glycine (0.125 M). The substrate samples were
removed and washed in a fresh tube containing 200 µl of PBS and vortexing for 10
seconds. One of the two substrate samples was removed for analysis. The other
sample underwent a second wash in a buffered detergent solution (PBS + 1% Triton X100). This sample was also removed and placed into a fresh tube for analysis.
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Figure 7: DNA binding after sonication

3.1.2.2 Sonication
The cells remaining from the crosslinking step were centrifuged at 4 x g for 5
minutes. The supernatant was removed. Then, 1 ml of sonication buffer (50 mM HEPES,
pH 7.8, 140 mM NaCl, 1 mM EDTA, 1% Triton X-100) was added and the cells were
resuspended. Two unused samples of the each substrate material were added to seven
different tubes. All tubes were kept on ice from this point forward. Sonication was
performed three times for 10 seconds at 5 watt power output. The two samples were
removed, one was subjected to a single wash and the other was washed twice as
described in the crosslinking step. Both samples were then kept in fresh tubes for
analysis.
3.1.2.3 Immunoprecipitation
Two new samples of the each substrate material were added to seven different
tubes. The solution remaining from the sonication step was centrifuged at 10 x g for 10
minutes. Due to fragmentation of cells and DNA in the sonication step, the DNA was
present in the supernatant. 500 µl of this supernatant was added to each of the seven

37

tubes along with 100 µl of an immunoglobulin (IgG) specific to the target DNA which was
lanosterol synthase gene. This gene was chosen because it is present as a single copy
in the human genome. This IgG was conjugated to agarose beads. The samples were
incubated for 3 hours with continuous mixing at 4 °C. Both the samples in each tube
were washed and removed for analysis as described above.

Figure 8: DNA binding after immunoprecipitation

3.1.3 Residual DNA Binding Analysis
All samples for analysis were heated to 95 °C in fresh tubes containing water for
10 minutes. Heating released the residual DNA from the sample surface into the water.
Polymerase chain reactions (PCR) was performed using this solution (95°C 15 seconds,
55°C 30 seconds, 45°C 72 seconds for 34 cycles) in order to amplify the DNA. For the
PCR reaction the following oligonucleotides were used. Sense: AGT GCT TGG TGA
GGC AGTTT; Antisense: CCT ACC CCC AGC CTA ACT TC. Visualization of amount of
DNA in the PCR output was done using an ultraviolet transilluminator. The output
intensity from the transilluminator was translated into the amount of DNA in each
sample. It should be noted that the output obtained from the transilluminator sometimes
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contains ‘smeared’ bands, instead of a single sharp one. This is a common result due to
overamplification of the PCR product, insufficient prior dilution, or too much genomic
DNA [135]. However, since all samples within a particular graph undergo PCR
amplification simultaneously, the results are still valid. The center sharp band is used for
comparison in these cases.
As previously mentioned, the first set of experiments was also performed along
with plasmid carrying the target DNA. Non-plasmid carrying samples were also tested
simultaneously for control. All samples in this set of experiment underwent only one
wash.

Figure 9: Single and double wash DNA binding after crosslinking

3.2 DNA Binding Analysis
Figure 6 compares the quantity of DNA removed from each substrate surface for
the crosslinking protocol done without the plasmid DNA with same experiment done in
the presence of plasmid DNA. The intensities obtained from the transilluminator are
shown below each corresponding bar. Lower bar height depicts lower non-specific
binding. Figure 7 and Figure 8 depict the results from the sonication and
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immunoprecipitation steps, with and without the plasmid DNA. These results also depict
similar trends. It is clear from the results that DNA exhibited the least binding to nanocrystalline diamond. These results are corroborated by the fact that they correspond
very well with the set containing the plasmid DNA. Since it was evident that good
amplification was obtained even without the plasmid DNA, this approach was discarded
in further experiments.

Figure 10: Single and double wash DNA binding after crosslinking

Figure 11: Single and double wash DNA binding after immunoprecipitation

Figure 9, Figure 10 and Figure 11 show outputs from double wash experiments.
There was an evident drastic decrease in the amount of DNA bound in all samples, due
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to the extra wash. However, note that all analyses were performed on separate samples.
Also, PCR on the one wash samples was done separately from the two wash samples.
Thus we cannot accurately quantify the percentage decrease in binding due to a wash.
Nevertheless, all results indicate nanocrystalline diamond consistently resulted in the
lowest quantity of non-specific DNA binding. Thus, it is potentially capable of offering
high sensitivity / high throughput when used in lab-on-chip devices.
However, nanocrystalline diamond has non-trivial overheads in form of
integration complexity and cost. The results show that SU-8 exhibited relatively on low
non-specific binding as well. This material is highly conducive to fabrication of
microfluidic devices, and may be a better option as a material, it might offer the best
compromise between sensititivity and ease of fabrication. Even though glass is widely
used, it consistently showed the worst non-specific binding, and thus can be concluded
to be an undesirable material when sensitivity and throughput are of importance.
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CHAPTER 4
CELL LYSIS ENHANCEMENT VIA NCD MICROSPIKES
4.1 Introduction
This research explores the use of micro-spikes on the microfluidic chamber walls
to enhance cell disruption. During ultrasonication the cells collide against the chamber
walls. During this collision, the array of spikes physically puncture the cell walls
increasing the efficiency of cell lysis.

Figure 12: Sketch of cell lysis unit

For this study, the material of choice for the micro-spikes was nanocrystalline
diamond (NCD). This research builds on the DNA binding research [136] which explores
the use of nanocrystalline diamond for microfluidic lab-on-a-chip, and establishes that
NCD exhibits the most resistance to non-specific DNA binding when compared to
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commonly used lab-on-a-chip building materials such as silicon, silicon dioxide, PDMS,
PMMA, glass and SU-8.
NCD is uniquely suited for cell lysis applications as its mechanical properties
[137] ensures that the micro-spikes would be the most robust to survive the vigorous
mechanical collisions they would be subjected to. Furthermore, NCD being a crystalline
material with a small grain size, a pyramidal spike-like structure made with it results in an
extremely sharp nanocrystalline tip. An increased efficiency of cell lysis via
ultrasonication would greatly increase the possibility of using mechanical lysis
techniques in lab-on-a-chip applications.

4.2 Fabrication of Microfluidic Chamber
The focus of this study was to evaluate the effect of using micro-spikes on cell
lysis via ultrasonication. The method of sonication was not the focus of this study
because different implementations might use a preferred type or design of sonicator.
The underlying physics behind cell lysis via ultrasonication would remain the same,
irrespective of the design of the sonicator. For this study a horn type ultrasonicator was
used for cell disruption.
Custom designed cell lysis units were built using polycarbonate (Lexan from GE).
Figure 12 schematically illustrates the chamber design, which included a microfluidic
chamber of 200 !l volume machined into a Lexan sheet. A similar sized thinner piece of
Lexan sheet was used to fabricate cover pieces for each microfluidic chamber. Identical
holes for screws were drilled through the cover pieces and into the chambers. A thin
rubber seal was placed in between each chamber and the cover piece to prevent
leakage, and screws were used to secure the pieces together, after loading the cells.
The rubber seal contained a rectangular cutout of exact dimensions of the chamber
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cross-section. The cutout was made to prevent the cells within the chamber from coming
in contact with the rubber seal.
Cell suspension of B16-F10 (ATCC CRL-6475) murine melanoma cells was
introduced into each microfluidic chamber via a micropipette. The rubber seal was then
aligned and placed over the chamber. The Lexan cover piece was placed on top of the
rubber seal, and the entire stack was tightened together with four screws, resulting in a
watertight seal.

Figure 13: Fabrication process flow of nanocrystalline diamond microspikes
(enhanced chamber flooring)
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Two types of cell lysis units were built for the purpose of this study. The first
type of unit) had a planar floor within the microfluidic chamber (henceforth referred to
as a ‘plain unit’. The other had nanocrystalline diamond microspikes at the bottom of
its microfluidic chamber (henceforth referred to as an ‘enhanced unit’). Figure 12
depicts an enhanced cell lysis unit. Several identical cell lysis units of both types
were built to perform simultaneous or subsequent experimental runs with varying
conditions. All units were identical in every respect except for the surface of the
flooring. MEMS processing techniques were used to fabricate the ‘enhanced’
flooring. Bare glass was used as the flooring for the plain units. The glass substrates
were permanently fixed into the Lexan cavities using cyano-acrylate adhesive, thus
forming the microfluidic chamber.

4.3 Fabrication of NCD Microspikes
Figure 13 schematically illustrates the process for fabrication of the microspikes.
Standard MEMS fabrication processes were used to make the flooring for the enhanced
cell lysis unit. A (100) n-type silicon wafer was used for fabrication. Wet oxidation of
silicon was performed to produce a 3000 Å silicon dioxide layer. Silicon dioxide was
patterned using lithography and wet etching via buffered oxide etch (BOE). The mask
used was comprised of an array of squares of 5 micron edge length having a pitch of 20
microns. Wet anisotropic etching was then performed using 25% KOH at 90ºC for about
10 minutes. This resulted in micropyramidal pits being formed on the silicon substrate
which were used as a template for the microspikes. This size of spikes’ base was
chosen because it is approximately same as the diameter of the cells.
The oxide mask was then removed using BOE. The patterned sample is then
ultrasonically pretreated in a mixture of nanodiamond and acetone slurry for 20
minutes followed by a sequence of ultrasonic rinse and clean steps.
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Figure 14: a) Optical image of NCD microspikes on glass substrate showing spike-like
structures b) SEM images of an array of microspikes c) SEM image of a single NCD
microspike.

The nucleation density achieved by this method of seeding is on the order of
1010cm-2. The nanocrystalline diamond (NCD) films were grown in a Cyrannus I Iplas
microwave-plasma enhanced chemical vapor deposition (MPECVD) reactor using 0.5 %
methane, 1 % hydrogen and remaining balanced with argon. The process parameters
were: Pressure - 135 Torr, Substrate temperature - 725°C, and a microwave power of
1.8 KW. The thickness of the NCD film was estimated to be ~ 1.5 micron. A 2 micron
layer of PECVD silicon dioxide was then deposited over the nanocrystalline diamond.
This layer served as an adhesion layer between the NCD layer and the subsequently
deposited gold layer. It also serves to fill up most of the pyramidal cavity, planarizing the
surface to some degree. This is followed by evaporation of 3000 Å of gold (over 300 Å of
chrome adhesion layer). Electroplating of gold is then performed to produce a 1.8-2
micron layer. The thick layer of gold completely planarizes the surface of the wafer. The
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electroplating was done at a high current density to result in a softer gold layer and thus
more conducive to thermocompression bonding.
A glass wafer (Corning 7740) was taken separately and similar evaporation and
electroplating processes were performed on it. The two wafers were then bonded via
thermocompression bonding of gold at 400N force for 20 minutes using an EVG 501
universal bonder. This results in a glass-gold-SiO2-NCD-Si stack. The entire stack was
then subjected to a 25% TMAH etch at 95ºC until all the silicon was dissolved (about 8
hours). This resulted in upright nanocrystalline diamond spikes over a glass substrate.
Figure 14 shows an image of the spike like microspikes taken through a high
magnification optical microscope. The image was taken at an angle to show the
microspikes, and thus only part of the image is in focus.
The glass wafer was then diced to required dimensions in order to precisely fit
the Lexan cavity. Bare glass wafers were also diced to the same dimensions forming
floorings for the plain cell lysis units.

4.4 Experimental Protocol
This study was conducted using B16-F10 (ATCC CRL-6475) murine melanoma
cells. The adherent B16 cells were grown in standard tissue culture flasks (Costar 3000;
Corning Inc., Corning, NY) in McCoy’s 5A medium (MediaTech Inc., Herndon, VA)
supplemented with 10% (v/v) fetal bovine serum (MediaTech Inc., Herndon, VA) in a 37
°C humidified atmosphere that contained 5% CO2. Cells were prepared for
experiments by trypsinization and then washing the harvested cells by centrifugation
(225 x g) 3 times in phosphate buffered saline. The resulting washed cell suspension
was further prepared by determining viability using the trypan blue dye exclusion test.
Cell cultures that were >95% viable were used for experimentation. Before each
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experiment, the suspension of harvested cells was adjusted to a concentration of 1
million cell per ml based upon enumeration in a standard hemacytometer.
Each experimental set employed three cell lysis units. The first unit was a
control unit, which did not undergo any sonication (a plain cell lysis unit was used). The
other two units were a plain and an enhanced cell lysis unit, both of which underwent
sonication. 75 µl of cell suspension was introduced at the same time into all three
microfluidic chambers. The plain and enhanced units were immersed in water (inside a
beaker), and an ultrasonic horn was used for lysis (Misonix – Sonicator 3000, #” probe –
misonix part #200, operating amplitude 120 !m, operating frequency 20kHz). The
sonication was carried out for 2 minutes at 69W. After sonication, cell lysis units were
opened and 50 µl of SYTOX green dye was mixed with all three cell suspensions.
SYTOX Green dye is an unsymmetrical cyanine stain with three positive charges and
has a high-affinity for nucleic acids. The dye cannot penetrate the intact membranes of
live cells, but easily penetrates cells with compromised plasma membranes. The dye
exhibits a 100 to 500-fold increase in fluorescence when it is bound to any kind of
nucleic acid that is present inside cells. Hence the dye fluoresces when it penetrates
lysed cells and binds to nucleic acids, or when it binds to nucleic acids that are outside
the cell. Therefore, it is an indicator of lysed cells. Spectrafluorometric analysis was
performed on all three samples. Comparison of fluorescence data from the cell
suspensions was a measure of the relative amount of lysed cells. Thus, by comparing
the fluorescence the relative efficiency of the cell lysis can be evaluated.

4.5 Results
Multiple sets of experiments were carried out using the above protocol. Each set
contained a control unit (no sonication), a plain cell lysis unit and an enhanced cell lysis
unit. Within each set, cells from the same harvested crop of B16 cell were used to
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ensure equal number of cells is present in each unit. Care was taken that the cells are
introduced into the microfluidic chambers at the same time, to ensure equal viability of
cells. Every separate set of experiment was performed with a different crop of cells to
establish a definitive trend. Half of the sets employed cell suspensions without any celldisruption beads. The other sets used 0.5 mm diameter glass cell-disruption beads. Ten
glass beads were introduced into each chamber along with the cell suspension, and the
cell-lysis protocol was carried out. Figure 15 depicts the results obtained from different
sets of experiments that did not use the disruption beads. Figure 16 depicts results with
sets using glass beads.

Figure 15: Ultrasonic cell lysis (without disruption beads).

Typically, there were a few nonviable cells in any prepared batch of B16 cells.
These cells represent the normal quantity of dead cells in any culture, losses in viability
due to repeated centrifugation, pipetting, and other manipulations that were necessary to
have an enumerated cell suspension to load into the chambers. As noted above, all
cells use for these experiments were >95% viable. Since a single cell suspension was
used for all units within a set, and the units were employed concurrently. Therefore, the
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fluorescence data for control samples represents the minimum number of nonviable
cells. This number was also present in the ultrasonically treated samples; therefore,
increases in fluorescence in these samples could be attributed to ultrasonic lysis.

Figure 16: Ultrasonic cell lysis (with glass disruption beads)

Three sets of lysis experiments (without beads) were repeated and the numbers
of alive cells were counted in the control, plain and enhanced cell lysis unit using a
standard hemacytometer. Figure 17 depicts the concentration of viable cells after
completion of the sonication. The starting viable cell concentration was 1 million/ml.
Time required for experimental run was about an hour and the loss in viable cell
concentration of the control is typical for this period. It is evident from the results that the
efficiency of cell lysis via ultrasonication was greatly enhanced when micro-spikes were
present on the chamber walls. The increase in cell-lysis efficiency was consistent across
all sets of experiments. It should be noted that each set of experiment was performed
with a different cell crop; thus the total number and viability of cells varied slightly from
set to set. It can be seen in Figure 15, that plain sonication resulted in a very small
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increase in fluorescence that averaged about 28%. However under the same
conditions, the presence of spikes at a chamber wall resulted in 392% increase in
fluorescence relative to the controls.

Figure 17: Concentration of viable cells after sonication

In the experiments where glass beads were present, the efficiency of cell lysis
was found to be greater than that without beads. As seen in Figure 16, with beads
present the fluorescence increased by an average of 93%. Thus the beads assist to a
certain degree in cell lysis via ultrasonication when compared to the control and the
same treatment that did not use beads. However, the fluorescence of samples in the
enhanced unit recorded a 414% increase with beads being present. In the cell count
experiments, the concentration of viable cells remaining in the enhanced chamber is
nine times less that those in the plain chamber.
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4.6 Conclusion
The results verify that a substantial increase in cell lysis efficiency can be
obtained by using micro-spikes along the microfluidic chamber walls. Even when spikes
were present only on one chamber wall, the increase in dead cell count was about 400%
- substantially more than without spikes. The efficiency of cell lysis should increase even
further if similar micro-spikes are used on multiple walls.
Even though use of glass disruption beads increased the cell lysis efficiency, this
increase was not as pronounced as that with use of micro-spikes. It is interesting to note
that with use of microspikes, the efficiency benefits of using disruption beads become
minimal (414% vs. 392%). For a typical microfluidic application, the inherent
disadvantages and inconvenience of handling glass beads in a lab-on-a-chip would
greatly overshadow the performance benefits.
It was seen that even after repeated use for ultrasonication and intermediate
wash cycles, performance of the nanocrystalline diamond microspikes did not decrease.
Thus, NCD proved to be a robust material for such an application. Upon visual
inspection, the microspikes survived multiple experiments without any discernable
damage. The authors envision that portable lab-on-a-chip applications that use MEMS
based ultrasonicator for cell lysis would greatly benefit from such a microfluidic chamber
construction due to their inherent power limitations.
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CHAPTER 5
SILICON MICRONEEDLES

5.1 Introduction
Advanced bioengineered systems have the potential to close the loop between
diagnostic and therapeutic elements employed in modern treatment techniques, thus
constituting a “smart” system. Many such systems will involve the transfer of physical
entities through the skin. Traditional approaches used to collect biofluids or deliver drugs
through the skin include needle puncture, electroporation or removal of the stratum
corneum through gels or tapes; all being reasonably intrusive. A minimally invasive
method for sampling or delivering biological fluids is essential to autonomous therapy
systems. Microneedles can achieve this task with significantly less trauma since their
sharp tips and short lengths reduce the odds of encountering a nerve.
The outermost layer of the epidermis, stratum corneum, is a thin, flexible, high
impedance biopolymer composed of interconnected dead cells. This layer is the major
barrier to various environmental insults (climatic, toxic from xenobiotics, or microbial),
and needs to be punctured for fluid transfer. Below the stratum corneum lies the viable
epidermal layer that is devoid of blood vessels and contains very few nerve endings. The
thickness of stratum corneum and viable epidermis of typical human skin are 10-40 !m
and 50-100!m respectively [131, 132].
A critical design parameter in the fabrication of microneedles is the compromise
between structural rigidity and ease of penetration. Due to elasticity of skin, a
considerable amount of deformation takes place around the insertion site, significantly
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reducing the insertion depth of microneedles [130]. To mitigate the undesirable effects
of skin deformation, the pressure applied by the needle tips needs to be increased.
Insertion pressure can be increased by raising the applied force, or, by increasing the
needle sharpness. An increase in applied force intensifies the strain on the
microneedles and may cause undue breakage. Furthermore, it may also magnify the
patient’s discomfort. Vibratory actuation has been suggested to decrease the force
required for insertion [133]. However, this requires the use of a vibratory actuator, which
may not be possible for all applications, or might complicate the design requirements.
Permeation of microneedles can also be improved by increasing their sharpness.
However, this is quite often achieved at the expense of structural rigidity. The needles
must be capable of tolerating stresses related to the non-uniformity of skin contour,
inadvertent slippage during insertion or removal, and reasonable human movements
during period of penetration. Microneedles with extremely sharp tips, but thin needle
bodies have been employed with successful penetration into skin [134]. However,
structural damage after insertion was reported, as can be expected due to compromised
sidewall thickness.
In this study, hollow microneedles with sharpened sidewall tips have been
fabricated without any reduction to the needle shaft diameter. Since the microneedle
sidewalls are sharpened only at the tip and not over the entire length of the needle, the
mechanical stiffness is maintained, while reducing the insertion force. The outlined
process achieves needle formation and tip sharpening in a continuous single-step
process, greatly reducing the complexity of fabrication. Using this process, extremely
sharp sidewalls can be obtained greatly reducing the penetration force. Furthermore,
since the process uses dry etching, a simple change in etch recipe can result in different
sidewall tip angles.
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5.2 Fabrication of Silicon Microneedles
The silicon microneedles were fabricated using a 4 inch, 400 !m thick, <100>
oriented, double side polished silicon wafer. The lithographic mask set contained various
microneedle arrays with sizes ranging from 33 gauge to 36 gauge. First, lithography was
performed on the backside of the wafer using photoresist AZ P4620. This step patterned
the wafer with circular holes outlining the through-wafer microfluidic channels for fluid
delivery. Next, DRIE was performed on the backside of the wafer, forming approximately
200 !m deep holes. Lithography was then performed on the front side of the wafer,
again using photoresist AZ P4620. The corresponding mask used was a bright field
mask, which patterned annular rings on the front side of the wafer. This step outlined the
microneedle sidewalls. Next, DRIE of silicon was done to form the microneedles. This
step was precisely timed to obtain the desired length of the needles.
It is important to note that no hard mask is used for etching the microneedles.
This is because the sharpening of the microneedle tips depends upon controlled
depletion of the photoresist. Depending on the duration of the second DRIE step, the
etching at this step might cease before the desired needle lengths are obtained. This is
because due to loading effects in DRIE the needle bores etch faster than the exposed
bulk region of the wafer. As soon as a through-hole is formed at any part of the wafer,
helium present at the backside of the wafer (for cooling) escapes into the main chamber,
breaking the plasma. At this stage, the wafer needs to be mounted on an aluminum
chuck to proceed with further etching. A thermal grease (Cool-GreaseTM) is used at the
backside of the wafer to dissipate heat. DRIE of silicon is continued for the requisite time
remaining. The wafer is then solvent-cleaned to remove the photoresist and the thermal
grease.
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5.2.1 Sharpening of Microneedle Tips
The sharpening of microneedle tips is based on precise timing of the second
DRIE step and controlled depletion of the photoresist. In the Alcatel DRIE system at
USF, the photoresist gets depleted at approximately 0.16 to 0.20 !m/minute during
silicon DRIE via Bosch process. Thus, the maximum length of microneedles that can be
obtained is limited by the thickness of photoresist used. When most of the photoresist
has been depleted (less than 1.5 !m thick), the resist loses its resolution, and starts
getting etched from the sides as well. Thus, it is observed that for the last few minutes
before complete depletion, the feature width of the resist reduces resist gradually. This
reduction of resist feature width corresponds to reduction of the annular ring area
forming the protective mask. The outer diameter of the annular ring gets reduced while
the inner diameter increases.

Figure 18: Sharpening of microneedle needle tips via gradual reduction of photoresist
mask
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Figure 19: Fabrication process of sharpened silicon microneedles

The gradual change in photoresist mask size during the DRIE causes a tapered
etch profile to be created. This has been depicted in Table 1. The taper angle depends
upon the etch rate of silicon as well as the depletion rate of photoresist, i.e. the etch
selectivity. By reducing the selectivity between photoresist and silicon, a higher taper
angle can be obtained.
A reduction in selectivity can be brought about by appropriate changes in the
DRIE recipe. In general, anisotropic etch processes depend heavily on ion-driven
chemical interactions between adsorbed fluorine-containing species and the silicon

57

surface. Maximum etch rate conditions are achieved when the residence time of reactive
species is increased by using a lower total gas-flow rate or when the partial pressure of
the reactive precursor gas is increased. The plasma-generated neutral chemical species
do not readily etch the silicon surface, but do play a role in the photoresist etching. By
changing the interactive physical and chemical etching of photoresist and silicon the
selectivity can be varied. This is usually implemented in plasma etch systems by
independently controlling the power input to the plasma and the bias voltage applied to
the wafer. The relative numbers of neutral species and reactive ions depend on the
specific plasma operating parameters such as RF power input, gas residence time in the
plasma zone, total reactor pressure, and partial pressure of the individual precursor
gases [138]. In general, an increase in selectivity is brought about at the expense of a
reduced etch rate.
The vertical length of the taper profile was observed to vary from approximate 30
!m to 40 !m. It is important to precisely time the etch duration. As soon as the entire
resist is depleted, the microneedles are completely exposed to DRIE etching. The etch
rate observed in the Alcatel DRIE system ranges from 4 !m/minute to 10 !m/minute,
depending on the loading effect due the particular mask design. Thus, even a few
minutes of over etch can result in complete loss of the needle tip. At this stage, the
needle tip etches at about the same rate as the wafer base, thus limiting the maximum
length of the needle. The microneedle, very quickly becomes blunt during the over etch
phase. Table shows the thickness of the photoresist along with the corresponding
maximum length of microneedles obtained.

58

Table 1: Dependence of maximum microneedle length on photoresist thickness
Photoresist mask

Maximum length

thickness (AZ P4620)

of microneedles

6.2 !m

120 !m

7.6 !m

150 !m

10.3 !m

200 !m

Figure 20 shows SEM images of a partially tapered silicon microneedle. The top
view shows the tapering of a 45 !m sidewall down to 25 !m.

Figure 20: Partially tapered silicon microneedle

As etching proceeds, further sharpening of the microneedle takes place. Figure
21 shows SEM images of microneedles with further sharpened tips. Figure 22 shows the
top view of a silicon microneedle clearly depicting sharpening of the needle sidewall from
about 43 !m to less than 8 !m.
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Figure 21: Silicon microneedles with sharpened tips

Figure 22: Top view of silicon microneedle showing extent of tip tapering

At the precise point of the complete resist depletion extremely sharp needle tips
can be obtained. This is seen in Figure 23. The tip of these needles is in the sub-micron
range.
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Figure 23: Silicon microneedles with extremely sharp tips

It is essential to note that the tapering process takes place particularly fast as
compared to the preceding etching process. To obtain 200 !m long microneedles, a 55
minute DRIE etch is required. However, even a few minutes of over-etch beyond that
resisted depletion causes the needle tip to be compromised; resulting in blunt needles
as shown in Figure 24. Thus, extremely tight control of obtained photoresist thickness,
lithography and DRIE are required for successful fabrication.
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Figure 24: Over-etched silicon microneedles with blunt tips

5.2.2 Electron Shading and Micromasking Effect
It was observed that, when wafers of higher resistivity (100 to 200 ohm-cm) were
used, spike-like projections were formed at the inner and outer edge of the microneedle
sidewalls, as seen in Figure 25. This effect can be attributed to pattern dependent
charging in plasmas. In plasma processing, there exists a significant difference in
directionality between ions and electrons bombarding surfaces. This is a fundamental
consequence of ‘plasma sheath’ dynamics. Most of the ions impinge onto a wafer
surface at directions closer to the surface normal while most of the electrons arrive at
oblique angles of incidence. Thus, the electron flux is isotropic and the ion flux is
anisotropic along the surface normal. Current balance is accomplished when equal
fluxes of ions and electrons impinge onto each surface segment. The directionality
difference has no important repercussions for flat surfaces. However, it can significantly
perturb the current balance when the surface is patterned as a result of geometric
shading from the oblique electrons by the features that constitute the pattern [139]. The
phenomenon, termed “electron shading” [140]. In the case of microneedles, due to
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electron shading, there is a lack of ion flux impinging on the microneedle sidewalls. This
results in local negative charge build-up at the entrance of the trenches [141].
Due to the negative charge accumulation, positively charged reactive ions get
deflected away during DRIE etching. The greatest charge accumulation occurs at the
edges of the features. Thus the polymer deposited at the edges of the features during
the passivation step of the Bosch process, does not get completely etched away. This
remaining polymer acts like a small mask, resulting in ‘micromasking’. Due to the micromasking effect silicon spikes are formed at the edges of the microneedle sidewalls.
These spikes are also sometimes known as ‘black silicon’ or ‘silicon grass’ [142, 143].
The spikes formed due to electron shading and micromasking were removed by
a 45 second isotropic etch in an SF6/O2 plasma.

Figure 25: Silicon spike formation due to electron shading and micromasking effects

5.3 Skin Penetration Testing of Microneedles
In order to ascertain the advantage of microneedle tip sharpening, the variation
of skin penetration force with tip geometry was studied. 34 gauge needles etched to
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different levels of needle tip sharpness were fabricated, and the corresponding
penetration force was tested. Tests were carried out on human cadaver skin preserved
at -80°C.
The experimental setup consisted of a skin loading block and a needle
attachment block. The skin was mounted on in the 0.5 inch x 0.5 inch aluminum block
using double sided adhesive tape. The aluminum block, in turn, was attached to a
pension-compression load cell (LCFA-500gF sensing capacity, Omega Co.). The
internal construction of these load cells consists of a full four-arm Wheatstone bridge,
capable of producing repeatable measurements. The load cell was interfaced to one
channel load cell input, 16-Bit, RS-485 Data Acquisition Module (Superlogics-8016) to
obtain real time results. The load cell was supported on a steel block, mounted on a XY
stage with two 1 !m resolution manual micrometers screws (SM-13, Newport Co.).
A 4x4 array of 34 gauge silicon microneedles with 1000 !m pitch was mounted
on the needle attachment block using double-sided adhesive tape. This block was
supported on an XYZ stage with motorized micrometers (Z600 series Thorlabs
Motorized Actuators) with 1 !m resolution. The motorized actuators were controlled by a
custom-built LabVIEW program, which also displayed the real-time output from the load
cell. Real-time visual monitoring of the needle insertion was done by a long-distance
high magnification microscope. Video capturing was done via a camera mounted on the
microscope.
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Figure 26: Skin penetration testing setup using motorized actuators

Figure 27: Visual monitoring of microneedles insertion into skin

The skin was loaded on the load cell immediately after bringing it to room
temperature. At this point, and the reading from the load cell was allowed to settle down
for a few minutes. The micrometer actuators allow for precise control of the needle and
skin position. Through careful monitoring via the microscope, the needles were brought
extremely close to the skin surface as seen in Figure 27. In order to obtain reliable force
data, the microneedles were inserted at a slow rate off 50 !m/minute into the skin. The
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force output from the load cell and the distance travelled by the micrometer actuator
were recorded via the data acquisition system.
During microneedle insertion, the skin initially resists the penetration of the
needles. This is observed as a rise in the force output from the load cell. At the point of
microneedle insertion, the stratum corneum is ruptured and the needles undergo a
sudden movement into the skin. This sudden movement is translated by the load cell as
a corresponding drop in the measured force. All microneedles were observed to remain
intact after removal from skin.

Figure 28: Insertion force of silicon microneedles

Figure 28 depicts a graph of monitored force versus distance travelled by the
microneedles. From the graph, the particular set of microneedles used required a force
of about 180 gf to penetrate into skin.
In order to confirm that the force drop observed was indeed due to presence of
needles, a control experiment was carried out. In this case, a square piece of silicon
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wafer of the same size as the microneedle array was used instead, and pressed against
the skin. Figure 29 shows a typical result obtained from the control experiment. The
graphs obtained from the control experiments overlap with high degree of agreement
with the microneedle insertion tests. This shows that the skin deformation dynamics
remain similar in both cases.

Figure 29: Skin insertion control test without microneedles

5.3.1 Analysis of Microneedle Insertion Into Skin
Initial indentation into skin is accompanied by deformation of the skin surface.
Such deformation is typical of microneedle insertion into skin. For the purpose of
rudimentary analysis, the force transducer can be assumed to be a spring gauge. The
force measured by the gauge is translated from the compression of the spring. The
measured force gets compromised due to deformation of the skin.
Let CN be the compression of the spring at various intervals (N=1, 2, 3 etc.). Let
MN be the corresponding movement of the microneedles, and let SN be the deformation
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of the skin. The actual compression of the spring is mitigated by the skin deformation.
Therefore,
1)

CN = MN – SN

By Hooke's law (for spring constant K and Force FN):
2)

FN = - K x CN

3)

FN = - K x (MN - SN)

4)

MN = - FN/K + SN

For the lower range of movement, the skin deformation is comparable to the
microneedle movement, i.e. SN is in the same magnitude range as MN.
The graph plots FN vs. MN. From equation 3, it is clear that due to SN the graph
can be expected to be non-linear in the low range of needle movement. This is indeed
observed in Figure 28. As the needles continue further movement, the incident force on
the skin increases. This is accompanied by an increase in spring compression. However,
as the skin reaches its deformation limit, the value of SN starts becoming negligible as
compared to the microneedle movement MN. From equation 3 it is clear that as MN and
FN increase, and SN becomes comparatively negligible, the graph should start to become
linear. This again is observed in Figure 28.
The stratum corneum is the hardest layer of the skin. As soon as the stratum
corneum is ruptured, the lower layers of the epidermis provide much lower resistance to
the microneedle insertion. Thus it is expected that as soon as the insertion occurs, most
of the entire length of the needles get inserted into skin. It has been reported in literature
that due to skin deformation, the length of the needle penetrating into skin gets limited
and the entire length of needle does not penetrate [130].
The proposed insertion mechanism of microneedles into skin has been depicted
in Figure 30. Initially, the microneedle forms a slight indentation on the top surface of
skin as shown in Figure 30-a. As the microneedle moves further, the skin deformation
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increases, as shown in Figure 30-b. The skin gets deformed before rupturing due
inherent resistance to penetration. The amount of resistance ability of skin can be
thought of as a potential energy stored within it. When the energy incident via the
needles surpasses the potential energy within the skin, penetration occurs. At this point,
the penetration is relatively instantaneous, especially at high insertion forces. Figure 30c shows a post-insertion sketch of the microneedle. At the instant of penetration, the skin
(which is being pushed by the spring gauge at its back), moves slightly towards the
needle array, thus registering a force drop. As shown in the figure, as soon as the
stratum corneum ruptures, the microneedle travels as deep as possible into the skin.
The base of the array now touches the skin surface.

Figure 30: Microneedle insertion mechanism into skin

As seen from Figure 27, the thickness of the skin was much a higher (couple of
millimeters), as opposed to the 200 micron long needles. Thus, the needles are not
expected to touch the aluminum back-plate behind the skin. After the instant of insertion,
the silicon base continues to push against the skin, and the force registered continues to
rise in a similar fashion to the control experiment.
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5.4 Insertion Force Variation With Tip Geometry
To ascertain the variation of skin insertion force with variation in microneedle tip
geometry, microneedle arrays of the different tip sharpness were fabricated. A 4x4 array
of 200 micron long, 33 gauge needles were used for this analysis. Arrays with four
different sharpness levels were compared; completely blunt tip, partially sharpened tip
and very sharp tip. Fresh piece of cadaver skin was used for each of these tests. Care
was taken to perform the experiments immediately after the skin thawed out. This
ensured that drying of the skin did not play a role in the penetration measurements.
Table 2 shows the different needles used for the skin insertion tests.
Three sets of measurements were taken using each of the microneedle arrays
under investigation. The incident force applied by the needles was plotted against the
distance moved by the needles. The motorized actuators allowed for very precise control
of the distance moved by the needles.
Except for the blunt needles, a sharp drop in force was observed at moment of
insertion, for all the tests. Furthermore, all graphs contained only one instant of force
drop, as is expected. Figure 31 shows the result of one of the insertion force tests using
‘less sharp’ microneedles.
Figure 32 depicts a typical graph of insertion force measurement using partially
‘sharp’ needles, while Figure 33 depicts one of the results obtained from ‘very sharp’
needles. The results from these tests were tabulated as shown in Table 3.
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Table 2: Microneedles tip sizes used for skin insertion tests
Needle type

Tip area (!m2)

Blunt

18636.43

Less Sharp

11083.57

Sharp

3068.04

Very Sharp

185.98
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SEM Image

The load cell used for this testing was rated at 500gf. For the blunt microneedle
tests, the insertion into skin was not seen within 150% of this range. Since it is not
advisable to use the load cell beyond this range, needle insertion of the blunt needles
could not be observed.

Figure 31: Incident force of ‘less sharp’ microneedles
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Figure 32: Incident force of ‘sharp’ needles

Figure 33: Insertion force of ‘very sharp’ needles
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Table 3: Force of insertion for different microneedle array tips
Force of Insertion (gf)
Very Sharp
Test no.

Blunt Needles

Less Sharp Needles

Sharp Needles
Needles

1

Not observed

442.4

228.3

11.5

2

Not observed

478.78

199.8

11.3

3

Not observed

504.23

179.27

10.1

Average

N/A

475.14

202.46

10.97

The results of skin insertion tests, as seen from Table 3, clearly reveal a marked
decrease of insertion force with sharpening of microneedle tips. In order to ascertain the
dependence of tip area on insertion force, tip surface area of the three types of needles
was calculated after a visual inspection of the needle tips.
The tip area for the various microneedles was plotted versus the observed
insertion force. Figure 34 depicts the dependence of needle insertion force on
microneedle tip area. This dependence is seen to have the linear progression.
Microneedles penetrate through the skin at the critical puncture pressure. Since the
applied pressure is a function of applied force and tip area, the linearity seen in Figure
34 is expected, and, in fact corroborates the validity of the results. From the slope of the
graph, the average penetration pressure per needle was found to be 0.0395 gf/!m 2.
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Figure 34: Dependence of insertion force on microneedle tip area

5.4.1 Analysis of Results From Variation of Tip Geometry
It is observed that when insertion force is high, the needles penetrate almost
instantly. This is seen as a vertical drop in force at instant of insertion in Figure 30.
However, as the insertion force reduces, the force drop becomes more gradual, as seen
in Figure 32. The force drop is most gradual when the insertion force is lowest, as in the
case of ‘very sharp’ needles, and is seen in Figure 33. This shows that after the stratum
corneum ruptures, the needles penetrate smoothly and relatively slowly into the lower
epidermis when the penetration force is low. This is as opposed to a much faster,
almost instant penetration when the insertion force is high.
It should also be mentioned that all needles might not be penetrating at the same
instant. Although care was taken to align the needles along a plane parallel to the skin
surface, there might be slight staggering of the needle tips. Thus, at soon as one needle
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enters, the other would follow close behind; a mechanism that might only be quantified
with equipment of higher resolution.
5.4.2 Calculation of Skin Toughness
It has been postulated that when the energy delivered to the skin exceeds the
energy needed to create a tear in the skin, the needle inserts into skin [94]. A similar
approach was used by Pereira et. al. [144] to model tears into skin initiated and
propagated with scissors.
The work input, is related to the change in potential energy between unaltered
skin and the skin just prior to needle penetration.
Therefore, $W="F dx, where F is the force applied by the needle, x is the axial position of
the needle, and the boundaries of integration are from the point of needle contact with
the skin to the point of needle insertion.
The fracture toughness of the skin (Gp) depends on the interface area between the
needles and the skin, and the total work input.

Therefore,

"

x= x i
x= 0

Fdx = G p A ,

where Gp is the puncture fracture toughness and xi is the displacement where insertion
occurs. The left-had side of the equation, i.e. the potential energy, was calculated as the
area under the load versus displacement curve before penetration.
From the area under the curve for the ‘less sharp’, ‘sharp’ and ‘very sharp’ needles, the
fracture toughness of skin was calculated. The units were converted to the standard skin
toughness unit kJ/N2. The results are shown in Table 4.
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Table 4: Skin toughness measured via each microneedle
Area under
Type of

Skin

curve before
Microneedle

needle

point of

toughness
tip area

tip

penetration (gf

(kJ/m2)

!m)
Very
489.5809

185.98

26.32

8087.01

3068.04

26.35

22351.18

11083.57

20.16

Sharp
Sharp
Less
Sharp

The value of skin toughness measured from these experiments are very close to
the value of 30.1 kJ/m2 reported by Davis et. al. and even closer to the value of 26.9
kJ/m2 reported by Purslow et. al. [145].

5.5 Microneedle Fracture Strength Testing
It is imperative to know the fracture strength of microneedles in order to ascertain
their physical limits. However, analytical analysis of beams does not translate to the
micro-scale, and thus strength assumptions cannot be made. Needle failure due to axial
loads may be due to heterogeneous peak stresses within the bulk material. Usually
these peak stresses are the cause of needle failure, and fracture or buckling equations
based on homogeneity of the material consistently over-estimate the strength of needles
[94].
In order to test the microneedle strength, 200 micron tall needles were mounted
onto a rigid aluminum block whose movement could be controlled via micromotor
77

actuators. A 0.5 mm wide stainless steel post was attached to another aluminum block,
which was in turn mounted on the load cell.
By visual monitoring, the steel post was aligned axially along individual
microneedles, one at a time. The microneedle being tested was pressed against the
steel post at a rate of 50 microns/minute. Force and distance data was recorded along
with a video of the needle collapse.

Figure 35: Schematic of axial fracture test setup
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Figure 36: Microneedle aligned with steel post for axial testing. Inset: Microneedle
completely collapses with no stub remaining

Axial fracture testing was done on 36 gauge hollow silicon microneedles. The
microneedle is seen to collapse completely at its critical load. There was no bending of
the needle observed. Also needles collapse completely from the base, with no stub
remaining. Figure 36 shows a microneedle aligned axially with the steel post. Figure 37
shows the fracture force obtained, which is the peak incident force. The graph has slight
non-linearity seen during rise in the incident force. This is probably due to slight
inadvertent slippage of the needle over the steel post, or due to minimal buckling of the
needle itself. Due to low precision of the visual monitoring setup, it is not possible to
resolve any slippage or buckling of the needle. However, the setup is adequately
suitable to ascertain the peak incident force, which is the parameter of interest.
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Figure 37: Axial fracture test on 36 gauge microneedle

Table 5 shows the results of the axial fracture tests. The axial strength of the
smallest fabricated needles was at the upper range of the load cell failure rating. The 35
gauge needles were also tried, but did not fracture within the load cell usage limit.
Strength testing on the 33 and 34 gauge needles was not attempted since their strength
rating was expected to be much higher.

Table 5: Axial fracture strength of silicon needles
Axial Fracture Strength (gf)
Test no.

36-gauge needle

35 gauge needle

1

661.85

Out of range

2

874.47

Out of range

3

682.49

Out of range

Mean

739.6

N/A
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33 and 34 gauge

Test not performed

N/A

5.6 Shear Fracture Testing
The shear fracture strength of microneedles has not been reported. Microneedle
usage involves stresses related to the non-uniformity of skin contour, inadvertent
slippage during insertion or removal, and reasonable human movements during period
of penetration. These cause lateral forces to be applied on the needles. Breakage due to
shear is a common cause of needle failure. In these tests, shear strength of needles was
measured by aligning the needles perpendicular to the steel post used in the axial load
testing. The steel post was pushed against the microneedle tips at the speed of 50
microns/minute. Care was taken to align the post as high as possible for successful
needle breakage. This is because the measured shear force increases if the point of
lateral force is lowered. Tests were done on multiple needles within each array, till
reliable results were obtained. All the test needles were 200 micron long with a blunt tip
and varied only in their gauge sizes. The experiments were captured on video.

Figure 38: Schematic of shear fracture test setup
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Figure 39: Steel post aligned perpendicular to silicon microneedle for shear strength
testing

Figure 40: Shear fracture test on 33 gauge microneedle
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Graphs were plotted for each of the shear tests. Figure 40 shows a typical plot of
shear fracture tests. The point of force drop represents the instant when the needle
breaks. The results of shear testing are shown in Table 6.

Table 6: Axial fracture strength of silicon needles
Shear Fracture Strength (gf)
33 gauge

34 gauge

35 gauge

36 gauge

needle

needle

needle

needle

1

262.18

186.9

84.98

36.77

2

255.44

199.68

84.59

38.29

3

308.05

170.42

70.14

31.77

Mean

275.22

185.67

79.9

35.6

Test no.

The variation of shear force for different needle dimensions is shown in Figure
41.

Figure 41: Shear force variation for various needle dimensions
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CHAPTER 6
SILICON DIOXIDE MICRONEEDLES

Silicon Dioxide needles were fabricated in order to explore their use for drug
delivery or extraction of biofluids. Two types of microneedle lumen shapes were
investigated – circular and square. Both types of microneedles were fabricated to have
0.8 to 1 micron sidewall thickness and 100 to 120 micron height. The circular
microneedles had 50 micron diameter, while square microneedles had 50 micron edge
length.
Traditional fabrication methodologies employ lapping of bulk silicon, which
dramatically reduce the obtainable length of microneedles. Also, lapping is a harsh
process, and usually results in an uneven or sloping surface. This research involved
fabrication of silicon dioxide microneedles using silicon nitride as an etch–stop layer for
DRIE. The same nitride layer acts as an oxide barrier. This novel use of silicon nitride
results in no loss of the bulk silicon.

6.1 Fabrication of Silicon Dioxide Microneedles
Fabrication of silicon dioxide microneedles was done using 400 micron silicon
wafer. The process starts with deposition of PECVD silicon dioxide on top and PECVD
silicon nitride on bottom. Patterning of top oxide layer is done to form holes. This is
followed by DRIE etching of silicon. The bottom nitride layer acts as a DRIE etch-stop.
Thermal oxidation of silicon wafer is done to form microneedle sidewalls. The bottom
nitride layer acts as an oxidation barrier for the bottom side of the wafer. Wet etching of
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bottom nitride using phosphoric acid (has high selectivity to oxide). Finally wet etching of
silicon using TMAH is done to form out of plane silicon dioxide microneedles. Figure 42
depicts the fabrication process of silicon dioxide microneedles.

Figure 42: Fabrication process of Silicon Dioxide Microneedle

In this process it is critical for the silicon nitride to maintain integrity, otherwise a
backside Helium leak occurs during DRIE, ceasing the process. During fabrication
various nitride thickness were tried to achieve the desired result. Figure 43 shows a
silicon nitride membrane holding up a silicon alignment marker.
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Figure 43: Silicon nitride membrane holding up a silicon alignment marker

Figure 44: Ashing of photoresist over alignment markers

Due to loading effects in DRIE Bosch process larger areas get etched faster than
the smaller holes. This caused the alignment windows to get etched through before the
holes. Since this process does not require alignment, and the alignment markers in the
alignment windows were superfluous, these areas were covered up by photoresist.
However due to thermal effect the resist gets ashed. Finally, a polyimide tape was used
to cover these areas. This tape is compatible with DRIE plasma processing, and holds
up reliably during the dry etch.
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Figure 45: Ashing of photoresist over alignment markers

6.1.1 Flaring of Microneedle Tips
It was found that the fabricated microneedles flared at the tips. This result is due
to the ‘notching effect’ in DRIE. This is a well established undesirable effect in some
DRIE machine. When a dielectric etch-stop region is reached during DRIE, charge
accumulation takes place locally. This causes the impinging ions to deflect sideways.
Thus notching in the end region takes place. This effect has been widely studied, and
many modern machines employ special processes that do not result in this effect. The
machine used for this fabrication (Alcatel AMS 100 SDE) does not include the
company’s ‘HRM’ capability that removes this effect.
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Figure 46: Flaring at the tip of silicon dioxide microneedle

In order to remove the flare, a slight CMP step was employed prior to TMAH
based silicon etching. The wafer was etched back to approximately 2-3 micron. After,
CMP it was observed that the flares were removed as required.
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Figure 47: Circular silicon dioxide microneedle

Figure 48: Array of silicon dioxide microneedles
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Figure 49: Square silicon dioxide microneedle

6.2 Skin Penetration Testing of Microneedles Into Human Skin
Penetration force testing of microneedles was done on cadaver skin. The setup
was same as that used for silicon needle insertion tests. For the oxide needles, a 15 x15
array of the needles was used. No clear drop in force was seen as that observed in
silicon needles. This is because the needle tip area for oxide needles is extremely small.
Thus the penetration is expected to happen with just a few gram-force. Due to
irregularities of the skin surface, the plot of force obtained is a bit noisy at the low end.
Even though a few instances can be interpreted as needle insertion, distinguishing them
from noise cannot be certain. Thus the insertion force could not be tabulated.
Visual inspection of the needles through a camera showed that the needles were
clearly intact during insertion. Multiple insertion and retrieval did not result in breakage of
the needles. Faint images of the needles are seen through the microscope are circled in
Figure 50.
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Figure 50: Insertion of oxide microneedles into skin.

Figure 51: Skin penetration force of oxide needles
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Since, no reliable force date was obtained, in order to verify successful insertion;
as opposed to mere indentation), the needles were manually inserted into human
cadaver skin. Green tattoo dye was smeared at the back end of the needle arrays. The
dye gets transported through the needles via capillary forces. Histology of the skin
samples was performed to observe for breakages in the Stratum corneum. The skin was
fixed in 10% neutral buffered formalin, processed (standard processing) and embedded
in paraffin for sectioning and hematoxylin and eosin (H&E) staining. Figure 50 depicts
successful penetration of the needles. Green tattoo dye indicates successful penetration
of needles through the stratum corneum and part of epidermis.
To depict penetration of the entire array of needles, Photomicrographs were
taken of the length of the skin section (overlapping sections), and were merged using
PhotoShop Elements 6 (photomerge option) to piece together the entire length of skin.

Figure 52: Post penetration histology on human skin
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6.3 Fracture Strength Testing
Axial force testing was done using a similar setup for silicon needles. It was
observed that as opposed to silicon needles, the oxide needles did not collapse
instantly. Rather, in many cases, the needle broke a small part at a time, and in effect
was ground slowly to its base. This effect can be observed as multiple spikes in the axial
fracture force data.

Figure 53: Axial fracture testing of oxide needles
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Figure 54: Axial fracture strength of circular needles

Figure 55: Axial fracture strength of square needles
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The axial fracture force of circular needles was found to be slightly higher than
the square ones. This is similar to critical loading on circular versus square hollow
metallic beams. There too, the circular beams buckle later than the square ones.
However, the equations for buckling cannot be translated to microneedles as needles
failure is due to fracture because of peak stresses, rather than buckling.

Table 7: Axial fracture strength of silicon dioxide needles
Axial Fracture Strength (gf)
Circular

Square

needles

needles

1

2.5

2.17

2

3.86

2.08

3

3.1

2.00

Mean

3.15

2.08

Test no.

6.4 Shear Fracture Testing
Shear fracture of oxide microneedles was tested. The needles are so small as
compared to their silicon counterparts, all force data was seen as spikes rather than a
gradual rise in force. In one test it was possible to break multiple needles in a single
motion of the steel rod. In that case, spikes could be observed at the interval of 1000
microns, which corresponded to the array pitch.
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Figure 56: Shear fracture strength of oxide needles

Table 8: Shear fracture strength of silicon dioxide needles
Shear Fracture Strength (gf)
Test no.
Circular

Square

needles

needles

1

2.14

0.5

2

2.25

0.6

3

2.05

0.9

4

2.40

0.6

Mean

2.21

0.65
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Figure 57: Shear fracture strength of circular needles

Figure 58: Shear fracture strength of square needles
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It was observed that even though square needles had only slightly lower axial
fracture strength, their shear fracture strength was a order of magnitude lower.
6.4.1 Analysis of Silicon Dioxide Needle Fracture Results
The results of the axial fracture tests on the oxide needles show that the square
needles fracture much more easily as compared to the circular needles. This result is
expected as even in the ‘macro’ domain, the critical loading limits of circular posts is
much higher than those of square posts. However, the fabricated structures cannot be
assumed to be simple vertical hollow posts with uniform sidewall thicknesses.
Retardation of oxidation at sharp corners plays a very important role. Oxidation does not
take place uniformly in 2-D structures. The thickness of oxide obtained is much lower
around sharp corners, and the effect is even more pronounced in the case of concave
corners [146]; as are present in our fabrication process.

Figure 59: Oxidation retardation in square microneedles

Figure 59 shows a sketch of the oxidation retardation effect, in the case of
square microneedles. Due to this effect, the structural integrity of a square microneedle
is even lower than what can be expected from a needle having homogeneous sidewall
thickness. The much lower shear fracture strength of oxide microneedles can be
attributed to this effect.
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CHAPTER 7
FUTURE WORK AND CONCLUSION

7.1 Future Work
7.1.1 Extraction of Interstitial Fluid From Human Cadaver Skin
Research needs to be done to fill the gap in scientific literature regarding
interstitial fluid withdrawal using microneedle arrays. Microneedle arrays need to be
packaged and used in conjunction with a pump to extract biofluids from skin. The setup
can employ a Franz cell with cadaver skin as a membrane. Any colored liquid of low
viscosity may be used for initial tests.

Figure 60: Packaged microneedles for fluid extraction
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The needle array will have to be bonded to a glass microfluidic chamber at the
back end. The chamber would in turn be connected via PEEK microfluidic tubing to a
syringe pump. Interstitial fluid may be withdrawn from human skin using the syringe
pump and flow rates can be determined. A study can analyze the effect of microneedle
shape, microneedle diameter, array size and array pitch on the flow rates.
7.1.2 Optimization of DRIE Etching to Increase Oxide Needle Strength
DRIE process is essentially an accrual of a small isotropic etch in every Bosch
cycle resulting in an overall anisotropic etch. The isotropic etches result in sidewall
roughness, also known as scalloping effect. Figure 61 shows the SEM of a DRIE trench
clearly showing the scalloping of sidewalls. This feature, in effect, provides fracture
points for microneedles. By reducing the sidewall roughness, microneedle robustness
can be greatly increased. The research task can focus on changing the Bosch recipe in
the DRIE process to achieve greater sidewall smoothness.

Figure 61: DRIE trench depicting scalloping effect
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7.2 Conclusion
In this research, the geometry of silicon microneedles has been varied via DRIE
processing to yield sharpened tips. Sharpening of microneedle tips provides reduced
skin insertion force without compromising structural strength. Variation of skin insertion
force of microneedles with change in tip sharpness has been studied, and toughness of
human skin derived to be approximately 26 kJ/m2. The axial and shear fracture limits of
the microneedles have also been studied. Axial fracture of 36 gauge silicon needles
takes place at an average force of 740gf. Shear fracture force of silicon needles varies
from 275gf (33 gauge needles) to 35.6gf (36 gauge needles). Fracture limits of circular
and square shaped silicon dioxide needles show reduced strength of square needles;
which is pronounced in the case of shear fracture.
Skin interaction systems containing bio-engineered interfaces will revolutionize
the biomedical industry in the coming decades. They promise exceptional capabilities in
diverse transdermal diagnostic and therapeutic applications. Next generation therapeutic
methods using advances in genomics, proteomics, pharmacogenomics etc., will all
benefit from to the capabilities provided by these micro-components. Development of
customized instrumentation will enable real-time electrical, mechanical and
electrochemical measurements on the skin surface and also provide novel methods of
drug delivery. Micromachined needles form the technological foundation for bioengineered skin interfaces. These enabling components will be a common denominator
in design of human interface lab-on-a-chip systems.
It is evident that microfluidic approaches to diagnosis and therapeutics offer
multifaceted advantages over their conventional counterparts. However, successful
clinical implementation of such systems would entail overcoming numerous challenges
in areas of design, fabrication, electronics integration, deployment, testing, and data
interpretation among many others. The interdependencies between the various design
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variables

and

the

obtained

characteristics

are

highly

complex,

and

warrant

multidisciplinary research initiatives. Optimum utilization of this technology depends
upon our capacity to identify and resolve, qualitatively and quantitatively, the various
parametric entities involved.

102

REFERENCES
1.

Terry, S., A gas chromatography system fabricated on a silicon wafer using
integrated circuit technology. Ph. D. Thesis Stanford Univ., CA., 1975.

2.

Harrison, D., et al., Micromachining a miniaturized capillary electrophoresisbased chemical analysis system on a chip. Science, 1993. 261(5123): p. 895897.

3.

Jacobson, S., et al., High-speed separations on a microchip. Anal. Chem, 1994.
66(7): p. 1114-1118.

4.

Rasmussen, A., et al., Simulation and optimization of a microfluidic flow sensor.
Sensors & Actuators: A. Physical, 2001. 88(2): p. 121-132.

5.

Rasmussen, A. and M. Zaghloul. The design and fabrication of microfluidic flow
sensors. 1999.

6.

Andersson, H., et al., A valve-less diffuser micropump for microfluidic analytical
systems. Sensors & Actuators: B. Chemical, 2001. 72(3): p. 259-265.

7.

Nguyen, N. and T. Truong, A fully polymeric micropump with piezoelectric
actuator. Sensors & Actuators: B. Chemical, 2004. 97(1): p. 137-143.

8.

Liu, R., Q. Yu, and D. Beebe, Fabrication and characterization of hydrogel-based
microvalves. Microelectromechanical Systems, Journal of, 2002. 11(1): p. 45-53.

9.

Young, A., T. Bloomstein, and S. Palmacci, Contoured elastic-membrane
microvalves for microfluidic network integration. Journal of biomechanical
engineering, 1999. 121: p. 2.

10.

Burbaum, J. and N. Sigal, New technologies for high-throughput screening.
Current Opinion in Chemical Biology, 1997. 1(1): p. 72-78.

11.

Zheng, B., L. Roach, and R. Ismagilov, Screening of protein crystallization
conditions on a microfluidic chip using nanoliter-size droplets. JOURNALAMERICAN CHEMICAL SOCIETY, 2003. 125(37): p. 11170-11171.

12.

Roberge, D., et al., Microreactor technology: A revolution for the fine chemical
and pharmaceutical industries? Chemical Engineering & Technology, 2005.
28(3): p. 318-323.

13.

Bilitewski, U., et al., Biochemical analysis with microfluidic systems. Analytical
and bioanalytical chemistry, 2003. 377(3): p. 556-569.
103

14.

Shaikh, K., et al., A modular microfluidic architecture for integrated biochemical
analysis. Proceedings of the National Academy of Sciences, 2005. 102(28): p.
9745-9750.

15.

Marle, L. and G. Greenway, Microfluidic devices for environmental monitoring.
Trends in Analytical Chemistry, 2005. 24(9): p. 795-802.

16.

Sequeira, M., et al., Towards autonomous environmental monitoring systems.
Talanta, 2002. 56(2): p. 355-363.

17.

Madou, M., et al., Design and fabrication of CD-like microfluidic platforms for
diagnostics: microfluidic functions. Biomedical Microdevices, 2001. 3(3): p. 245254.

18.

Yager, P., et al., Microfluidic diagnostic technologies for global public health.
Nature, 2006. 442: p. 412-418.

19.

Andersson, H. and A. Van den Berg, Microfluidic devices for cellomics: a review.
Sensors & Actuators: B. Chemical, 2003. 92(3): p. 315-325.

20.

Helene, A., Lab-on chips for cellomics: micro & nanotechnologies for life science.

21.

Sanders, G. and A. Manz, Chip-based microsystems for genomic and proteomic
analysis. Trends in Analytical Chemistry, 2000. 19(6): p. 364-378.

22.

Lion, N., et al., Microfluidic systems in proteomics. Electrophoresis, 2003. 24(21).

23.

Jain, K., Applications of biochip and microarray systems in pharmacogenomics.
pgs, 2000. 1(3): p. 289-307.

24.

Ahn, C., et al., Disposable smart lab on a chip for point-of-care clinical
diagnostics. Proceedings of the IEEE, 2004. 92(1): p. 154-173.

25.

Srinivasan, V., V. Pamula, and R. Fair, An integrated digital microfluidic lab-on-achip for clinical diagnostics on human physiological fluids. Lab on a Chip, 2004.
4(4): p. 310-315.

26.

Daw, R. and J. Finkelstein, Lab on a chip. Nature, 2006. 442(7101): p. 367-367.

27.

Erickson, D. and D. Li, Integrated microfluidic devices. Analytica Chimica Acta,
2004. 507(1): p. 11-26.

28.

Lao, A., et al., Precise temperature control of microfluidic chamber for gas and
liquid phase reactions. Sensors & Actuators: A. Physical, 2000. 84(1-2): p. 11-17.

29.

Marentis, T., et al., Microfluidic sonicator for real-time disruption of eukaryotic
cells and bacterial spores for DNA analysis. Ultrasound in Medicine & Biology,
2005. 31(9): p. 1265-1277.

104

30.

Ko, J., et al., A polymer-based microfluidic device for immunosensing biochips.
Lab on a Chip, 2003. 3(2): p. 106-113.

31.

McDonald, J. and G. Whitesides, Poly (dimethylsiloxane) as a material for
fabricating microfluidic devices. Accounts of chemical research, 2002. 35(7): p.
491-500.

32.

Quake, S. and A. Scherer, From micro-to nanofabrication with soft materials.
Science, 2000. 290(5496): p. 1536-1540.

33.

Beebe, D., et al., Functional hydrogel structures for autonomous flow control
inside microfluidic channels. Nature a-z index, 2000. 404(6778): p. 588-590.

34.

Eteshola, E. and D. Leckband, Development and characterization of an ELISA
assay in PDMS microfluidic channels. Sensors & Actuators: B. Chemical, 2001.
72(2): p. 129-133.

35.

Bhansali, S., H. Thurman Henderson, and S. Hoath, Probing human skin as an
information-rich smart biological interface using MEMS sensors. Microelectronics
Journal, 2002. 33(1-2): p. 121-127.

36.

Gascoyne, P., J. Satayavivad, and M. Ruchirawat, Microfluidic approaches to
malaria detection. Acta tropica, 2004. 89(3): p. 357-369.

37.

Wolf, M., et al., Simultaneous detection of C-reactive protein and other cardiac
markers in human plasma using micromosaic immunoassays and self-regulating
microfluidic networks. Biosensors and Bioelectronics, 2004. 19(10): p. 11931202.

38.

Chung, Y., et al., Microfluidic chip for high efficiency DNA extraction. Lab on a
Chip, 2004. 4(2): p. 141-147.

39.

Yeung, S. and I. Hsing, Manipulation and extraction of genomic DNA from cell
lysate by functionalized magnetic particles for lab on a chip applications.
Biosensors and Bioelectronics, 2006. 21(7): p. 989-997.

40.

Gattiker, G., K. Kaler, and M. Mintchev, Electronic Mosquito: designing a semiinvasive Microsystem for blood sampling, analysis and drug delivery applications.
Microsystem Technologies, 2005. 12(1): p. 44-51.

41.

Newman, J. and A. Turner, Home blood glucose biosensors: a commercial
perspective. Biosensors and Bioelectronics, 2005. 20(12): p. 2435-2453.

42.

Tsuchiya, K., et al., Development of blood extraction system for health monitoring
system. Biomedical Microdevices, 2005. 7(4): p. 347-353.

43.

Ertl, P., et al., Development of a Lab-on-a-Chip for the Characterization of
Human Cells.

44.

Medoro, G., et al., A lab-on-a-chip for cell detection and manipulation. IEEE
Sensors Journal, 2003. 3(3): p. 317-325.
105

45.

Sabounchi, P., et al., Sample concentration and impedance detection on a
microfluidic polymer chip. Biomedical Microdevices, 2008. 10(5): p. 661-670.

46.

Khanna, P., et al., Microneedle-Based Automated Therapy for Diabetes Mellitus.
Journal of Diabetes Science and Technology, 2008. 2(6): p. 1122-1129.

47.

Zafar Razzacki, S., et al., Integrated microsystems for controlled drug delivery.
Advanced Drug Delivery Reviews, 2004. 56(2): p. 185-198.

48.

Dreher, F., et al., Interaction of a lecithin microemulsion gel with human stratum
corneum and its effect on transdermal transport. Journal of Controlled Release,
1997. 45(2): p. 131-140.

49.

Bashir, S., et al., Physical and physiological effects of stratum corneum tape
stripping. Official Journal of International Society for Bioengineering and the Skin
(ISBS) International Society for Digital Imaging of Skin (ISDIS) International
Society for Skin Imaging (ISSI), 2001. 7(1): p. 40-48.

50.

Marttin, E., et al., A critical comparison of methods to quantify stratum corneum
removed by tape stripping. Skin pharmacology: the official journal of the Skin
Pharmacology Society, 1996. 9(1): p. 69.

51.

Gebhart, S., et al., Glucose Sensing in Transdermal Body Fluid Collected Under
Continuous Vacuum Pressure Via Micropores in the Stratum Corneum. Diabetes
Technology & Therapeutics, 2003. 5(2): p. 159-166.

52.

Brazzle, J., I. Papautsky, and A. Frazier, Micromachined needle arrays for drug
delivery or fluid extraction. IEEE Engineering in Medicine and Biology Magazine,
1999. 18(6): p. 53-58.

53.

Kaushik, S., et al., Lack of pain associated with microfabricated microneedles.
2001, IARS. p. 502-504.

54.

Elias, P.M., The stratum corneum revisited. J Dermatol, 1996. 23(11): p. 756-8.

55.

Elias, P.M., Stratum corneum architecture, metabolic activity and interactivity with
subjacent cell layers. Exp Dermatol, 1996. 5(4): p. 191-201.

56.

Hoath, S.B., M.M. Donnelly, and R.E. Boissy, Sensory transduction and the
mammalian epidermis. Biosens Bioelectron, 1990. 5(5): p. 351-66.

57.

Kell, D., The principles and potential of electrical admittance spectroscopy: an
introduction. Biosensors: fundamentals and applications, 1987: p. 427–468.

58.

Nicander, I., et al., Correlation of impedance response patterns to histological
findings in irritant skin reactions induced by various surfactants. British Journal of
Dermatology, 1996. 134(2): p. 221.

59.

Rawlings, A.V., et al., Stratum corneum moisturization at the molecular level. J
Invest Dermatol, 1994. 103(5): p. 731-41.

106

60.

Sinclair, B., Everything's great when its sits on a chip - A bright future for DNA
arrays. Scientist, 1999. 13(11): p. 18-20.

61.

Structure of Skin, in Microsoft(r) Encarta(r) Encyclopedia. (c) 2004 -2004,
Microsoft Corporation. All Rights Reserved.

62.

Swanson, J.R. Epidermis. 1996 [cited 2009 10 Feb]; Available from:
<http://www.meddean.luc.edu/lumen/MedEd/medicine/dermatology/melton/skinls
n/epider.htm>.

63.

Marks, R. and J.-L. Leveque, The Essential Stratum Corneum: Introduction:
Martin Dunitz Ltd.

64.

Fujii, T., PDMS-based microfluidic devices for biomedical applications.
Microelectronic Engineering, 2002. 61: p. 907-914.

65.

Konrad, R., et al., Towards disposable lab-on-a-chip: poly (methylmethacrylate)
microchip electrophoresis device with electrochemical detection. Electrophoresis,
2002. 23: p. 596-601.

66.

Johnson, T.J., D. Ross, and L.E. Locascio, Rapid Microfluidic Mixing. Analytical
Chemistry, 2002. 74(1): p. 45-51.

67.

Chandrasekaran, S. and A. Frazier, Characterization of surface micromachined
metallic microneedles. Microelectromechanical Systems, Journal of, 2003. 12(3):
p. 289-295.

68.

Davis, S., et al., Hollow metal microneedles for insulin delivery to diabetic rats.
IEEE Transactions on Biomedical Engineering, 2005. 52(5): p. 909-915.

69.

Kim, K., et al., A tapered hollow metallic microneedle array using backside
exposure of SU-8. Journal of Micromechanics and Microengineering, 2004.
14(4): p. 597-603.

70.

Lee, S., W. Jeong, and D. Beebe, Microfluidic valve with cored glass microneedle
for microinjection. Lab on a Chip, 2003. 3(3): p. 164-167.

71.

Rajaraman, S. and H. Henderson, A unique fabrication approach for
microneedles using coherent porous silicon technology. Sensors & Actuators: B.
Chemical, 2005. 105(2): p. 443-448.

72.

Rodriguez, A., et al., Fabrication of silicon oxide microneedles from macroporous
silicon. Sensors & Actuators: B. Chemical, 2005. 109(1): p. 135-140.

73.

Park, J., M. Allen, and M. Prausnitz, Biodegradable polymer microneedles:
fabrication, mechanics and transdermal drug delivery. Journal of Controlled
Release, 2005. 104(1): p. 51-66.

74.

Park, J., M. Allen, and M. Prausnitz, Polymer microneedles for controlled-release
drug delivery. Pharmaceutical Research, 2006. 23(5): p. 1008-1019.

107

75.

Sung, J.-H., S.-J. Kim, and K.-H. Lee, Fabrication of microcapacitors using
conducting polymer microelectrodes. Journal of Power Sources, 2003. 124(1): p.
343-350.

76.

Gardeniers, H., et al., Silicon micromachined hollow microneedles for
transdermal liquid transport. Microelectromechanical Systems, Journal of, 2003.
12(6): p. 855-862.

77.

Paik, S., et al., In-plane single-crystal-silicon microneedles for minimally invasive
microfluid systems. Sensors & Actuators: A. Physical, 2004. 114(2-3): p. 276284.

78.

Wilke, N., et al., Silicon microneedle electrode array with temperature monitoring
for electroporation. Sensors & Actuators: A. Physical, 2005. 123: p. 319-325.

79.

Wilke, N., et al., Process optimization and characterization of silicon
microneedles fabricated by wet etch technology. Microelectronics Journal, 2005.
36(7): p. 650-656.

80.

Chandrasekaran, S. and A.B. Frazier. Mechanical Characterization of Surface
Micromachined Hollow Metallic Microneedles. in IEEE EMBS Special Topic
Conference on Microtechnologies in Medicine & Biology. May 2002. Madison,
WI.

81.

Stoeber, B. and D. Liepmann, Arrays of hollow out-of-plane microneedles for
drug delivery. Microelectromechanical Systems, Journal of, 2005. 14(3): p. 472479.

82.

Morrow, T., Transdermal patches are more than skin deep. Managed Care April
2004.

83.

Marks, R. and J.-L. Leveque, The Essential Stratum Corneum : Crossing the
Barrier: Martin Dunitz Ltd.

84.

Stoeber, B. and D. Liepmann. Fluid injection through out of plane micro needles.
in 1St annual international IEEE-EMBS, special topic conference on micro
technologies in medicine and Biology. 2000. LYON, France: IEEE.

85.

D.V.McAllister, et al., Micro Needles for Transdermal Delivery of Molecules. IEEE
1999: p. 836.

86.

J.G.E.Gardeniers, et al., Silicon micro machined hollow micro needles for
transdermal liquid transfer. IEEE 2002: p. 141-144.

87.

K.Liu, et al. Electroplated micro needle array for BIO medical applications. in
Proceedings of SPIE - The International Society for Optical Engineering. 2001.

88.

S.Henry, et al., Micromachined Needles for the Transdermal Delivery of Drugs, .
IEEE 1998: p. 494-498.

108

89.

Griss, P. and G. Stemme, Novel, Side Opened Out-of-Plane Micro Needles For
Microfluidic Transdermal Interfacing. IEEE 2002: p. 467-470.

90.

Brazzle, J., I. Papautsky, and A.B. Frazier., Micro Machined Needle Array For
Drug Delivery or Fluid Extraction. IEEE, 1999: p. 53- 58.

91.

D.Zahn, J., D. Trbotich, and D. Liepmann., Microfabricated MicroDialysis
Microneedles for Continuous Medical Monitoring. IEEE 2000: p. 375-380.

92.

V.McAllister, D., M. G.Allen, and M. R.Prausnitz., Microfabricated MicroNeedles
for Gene and Drug Delivery. Annual Review of BioMedical Engg., 2000: p. 289313.

93.

Friedl, K.E., Analysis: optimizing microneedles for epidermal access. Diabetes
Technol Ther, 2005. 7(3): p. 546-8.

94.

Davis, S.P., et al., Insertion of microneedles into skin: measurement and
prediction of insertion force and needle fracture force. Journal of Biomechanics,
2004. 37(8): p. 1155-1163.

95.

Wijaya Martanto, S.M.B., Elizabeth A. Costner, Mark R. Prausnitz, Marc K.
Smith,, Fluid dynamics in conically tapered microneedles. AIChE Journal, 2005.
51(6): p. 1599-1607.

96.

Mukerjee, E., et al., Microneedle array for transdermal biological fluid extraction
and in situ analysis. Sensors & Actuators: A. Physical, 2004. 114(2-3): p. 267275.

97.

Collison, M., et al., Analytical characterization of electrochemical biosensor test
strips for measurement of glucose in low-volume interstitial fluid samples. Clinical
Chemistry, 1999. 45(9): p. 1665-1673.

98.

Wang, P., M. Cornwell, and M. Prausnitz, Minimally invasive extraction of dermal
interstitial fluid for glucose monitoring using microneedles. Diabetes Technology
& Therapeutics, 2005. 7(1): p. 131-141.

99.

Brazzle, J., I. Papautsky, and A.B. Frazier, Micromachined needle arrays for drug
delivery or fluid extraction. Engineering in Medicine and Biology Magazine, IEEE,
1999. 18(6): p. 53-58.

100.

Moon, S. and S. Lee, A novel fabrication method of a microneedle array using
inclined deep x-ray exposure. Journal of Micromechanics and Microengineering,
2005. 15(5): p. 903-911.

101.

Martanto, W., et al., Microinfusion using hollow microneedles. Pharmaceutical
Research, 2006. 23(1): p. 104-113.

102.

Perennes, F., et al., Sharp beveled tip hollow microneedle arrays fabricated by
LIGA and 3D soft lithography with polyvinyl alcohol. Journal of Micromechanics
and Microengineering, 2006. 16(3): p. 473-479.

109

103.

Griss, P. and G. Stemme, Novel, Side Opened Out-of-Plane Micro Needles For
Microfluidic Transdermal Interfacing. IEEE, 2002: p. 467-470.

104.

Zhang, P. and G. Jullien. Microneedle arrays for drug delivery and fluid
extraction. 2005.

105.

Zahn, J., et al., Microfabricated polysilicon microneedles for minimally invasive
biomedical devices. Biomedical Microdevices, 2000. 2(4): p. 295-303.

106.

Khanna, P., et al., The Challenge of Human Skin - Engineering the Biotic/Abiotic
Interface, in Smart Biosensor Technology, G.K. Knopf and A.S. Bassi, Editors.
2007, CRC Press. p. 249-268.

107.

Melin, J. and S. Quake, Microfluidic large-scale integration: the evolution of
design rules for biological automation. 2007.

108.

Nisisako, T. and T. Torii, Microfluidic large-scale integration on a chip for mass
production of monodisperse droplets and particles. Lab on a Chip, 2008. 8(2): p.
287-293.

109.

Spencer, V., et al., Chromatin immunoprecipitation: a tool for studying histone
acetylation and transcription factor binding. Methods, 2003. 31(1): p. 67-75.

110.

Wang, S., et al., Optical properties of nano-crystalline diamond films deposited
by MPECVD. Optical Materials, 2003. 24(3): p. 509-514.

111.

Müller, R., et al., Elements for surface microfluidics in diamond. Diamond &
Related Materials, 2004. 13(4-8): p. 780-784.

112.

Björkman, H., et al., Diamond replicas from microstructured silicon masters.
Sensors & Actuators: A. Physical, 1999. 73(1-2): p. 24-29.

113.

Guillaudeu, S., X. Zhu, and D.M. Aslam, Fabrication of 2-[mu]m wide polycrystalline diamond channels using silicon molds for micro-fluidic applications.
Diamond and Related Materials, 2003. 12(1): p. 65-69.

114.

Massi, M., et al., Plasma etching of DLC films for microfluidic channels.
Microelectronics Journal, 2003. 34(5-8): p. 635-638.

115.

Hartl, A., et al., Protein-modified nanocrystalline diamond thin films for biosensor
applications. Nat Mater, 2004. 3(10): p. 736-742.

116.

Lasseter, T., et al. 8th International Conference on Applications of Diamond and
Related Materials. 2005.

117.

Nebel, C., et al., Photochemical attachment of amine linker molecules on
hydrogen terminated diamond. Diamond & Related Materials, 2006. 15(4-8): p.
1107-1112.

118.

OkrÛj, W., et al., Blood platelets in contact with nanocrystalline diamond
surfaces. Diamond and Related Materials, 2006. 15(10): p. 1535-1539.
110

119.

Xu, Z., A. Kumar, and A. Kumar, Amperometric detection of glucose using a
modified nitrogen-doped nanocrystalline diamond electrode. Journal of
Bioscience and Nanotechnology, 2005. 1: p. 416-420.

120.

Xu, Z., et al. Synthesis and Characterization of Nanocrystalline Diamond Film
and Its Biomedical Applications. in MRS Symposium Proceeding. 2004.

121.

Björkman, H., et al., Diamond microchips for fast chromatography of proteins.
Sensors & Actuators: B. Chemical, 2001. 79(1): p. 71-77.

122.

Christiaens, P., et al., EDC-mediated DNA attachment to nanocrystalline CVD
diamond films. Biosensors and Bioelectronics, 2006. 22(2): p. 170-177.

123.

Karczemska, A. and A. Sokolowska. Wide Bandgap Layers, 2001. Abstract
Book. 2001.

124.

Takahashi, K., et al., DNA preservation using diamond chips. Diamond & Related
Materials, 2003. 12(3-7): p. 572-576.

125.

Belgrader, P., et al., A Minisonicator To Rapidly Disrupt Bacterial Spores for DNA
Analysis. Analytical Chemistry, 1999. 71(19): p. 4232-4236.

126.

Mello, A.J.d. and N. Beard, Dealing with real samples: sample pre-treatment in
microfluidic systems. Lab on a Chip, 2003. 3: p. 11N - 20N.

127.

Dong Woo, L. and C. Young-Ho. A Continuous Cell Lysis Device Using Focused
High Electric Field and Self-Generated Electroosmotic Flow. in Micro Electro
Mechanical Systems, 2006. MEMS 2006 Istanbul. 19th IEEE International
Conference on. 2006.

128.

Lee, S.W., H. Yowanto, and Y.C. Tai. A micro cell lysis device. in Micro Electro
Mechanical Systems, 1998. MEMS 98. Proceedings., The Eleventh Annual
International Workshop on. 1998.

129.

Kim, J., et al., Cell lysis on a microfluidic CD (compact disc). Lab on a Chip,
2004. 4(5): p. 516-522.

130.

Martanto, W., et al., Mechanism of fluid infusion during microneedle insertion and
retraction. Journal of Controlled Release, 2006. 112(3): p. 357-361.

131.

Elias, P.M., The stratum corneum as an organ of protection: old and new
concepts. Curr Probl Dermatol, 1989. 18: p. 10-21.

132.

Schmidt, R.F. and G. Thews, Human physiology. 2nd completely rev. ed. 1989,
Berlin ; New York: Springer-Verlag. xviii, 825 p.

133.

Yang, M. and J.D. Zahn, Microneedle Insertion Force Reduction Using Vibratory
Actuation. Biomedical Microdevices, 2004. 6(3): p. 177-182.

111

134.

Sebastien Henry, D.V.M., Mark G. Allen, Mark R. Prausnitz,, Microfabricated
microneedles: A novel approach to transdermal drug delivery. Journal of
Pharmaceutical Sciences, 1998. 87(8): p. 922-925.

135.

Hillis, D.M., C. Moritz, and B.K. Mable, Molecular systematics. 2nd ed. 1996,
Sunderland, Mass.: Sinauer Associates. p. 231.

136.

Khanna, P., et al., Use of nanocrystalline diamond for microfluidic lab-on-a-chip.
Diamond and Related Materials, 2006. 15(11-12): p. 2073-2077.

137.

Kulisch, W., et al., Mechanical properties of nanocrystalline diamond/amorphous
carbon composite films prepared by microwave plasma chemical vapour
deposition. Diamond & Related Materials, 2004. 13(11-12): p. 1997-2002.

138.

Chambers, A.A., Selectivity/etch rate trade-offs in deep and high A/R oxide
etching. Solid State Technology, 2005. 48(2).

139.

Hwang, G.S. and K.P. Giapis, Pattern-dependent charging in plasmas. Ieee
Transactions on Plasma Science, 1999. 27(1): p. 102-103.

140.

Mise, N., et al. Pattern-size effect on electron shading. in Plasma ProcessInduced Damage, 2000 5th International Symposium on. 2000.

141.

Kamata, T. and H. Arimoto, Charge build-up in Si-processing plasma caused by
electron shading effect. Journal of Applied Physics, 1996. 80(5): p. 2637-2642.

142.

Dixit, P. and J. Miao, Effect of Clamping Ring Materials and Chuck Temperature
on the Formation of Silicon Nanograss in Deep RIE. Journal of The
Electrochemical Society, 2006. 153(8): p. G771-G777.

143.

Karola Richter, C.K., Johann-Wolfgang Bartha,, Micro-Patterned Silicon Surfaces
for Biomedical Devices. Plasma Processes and Polymers, 2007. 4(S1): p. S411S415.

144.

Pereira, B.P., P.W. Lucas, and T. SweeHin, Ranking the fracture toughness of
thin mammalian soft tissues using the scissors cutting test. Journal of
Biomechanics, 1997. 30(1): p. 91-94.

145.

Purslow, P.P., Measurement of the Fracture-Toughness of Extensible
Connective Tissues. Journal of Materials Science, 1983. 18(12): p. 3591-3598.

146.

Plummer, J.D., M.D. Deal, and P.B. Griffin, Silicon VLSI technology :
fundamentals, practice, and modeling. Prentice Hall electronics and VLSI series.
2000, Upper Saddle River, NJ: Prentice Hall. p. 333-335.

112

APPENDICES

113

Appendix A: Microneedle Gauge Sizes

33 gauge: Inner Diameter - 100 micron; Outer Diameter 200 micron
34 gauge: Inner Diameter - 85 micron; Outer Diameter 160 micron
35 gauge: Inner Diameter - 65 micron; Outer Diameter 130 micron
36 gauge: Inner Diameter - 30 micron; Outer Diameter 100 micron
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Appendix B: Photolithography Recipe for AZ4620

Step 1: Spin HMDS at 3500 rpm for 30 seconds.
Step 2: Spin photoresist AZ4620 at 500 rpm for 10 seconds followed by 2500 rpm for 60
seconds.
Step 3: Soft bake in oven at 90°C for 20 minutes.
Step 4: Leave wafer at ambient temperature for 1 hour to rehydrate resist.
Step 5: Expose in Karl-Suss aligner for 55 seconds at 25 mW/cm2 intensity.
Step 6: Develop in 1:1 AZ400K:H2O for 4 minutes.
Step 7: Hard bake in oven at 90°C for 20 minutes.
Result: Photoresist thickness obtained is approximately 6.6 to 7 micron.
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Appendix C: Silicon DRIE Recipe

Etch step gases

SF6 and 300 sccm with 3 second cycle.

Passivation step gases

C4F8 at 200 sccm with 1.4 second cycle, and O2 at
20 sccm with 1.4 seconds cycle

Pressure:

5.25 x 10-1 mTorr

Source generator power:

2400 W

Substrate holder power:

Used in pulsed mode
High cycle at 100 W for 25 millisecond
Low cycle at 0 W for 75 millisecond

Substrate holder He pressure:

9.75 x 10-3 mTorr

Bias Voltage:

-185 V (negative)
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